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“All models are wrong but some are useful” 
“Now it would be very remarkable if any system existing in the real world could be exactly 
represented by any simple model. However, cunningly chosen parsimonious models often 
do provide remarkably useful approximations. For example, the law PV = RT relating pres-
sure P, volume V and temperature T of an ‘ideal’ gas via a constant R is not exactly true for 
any real gas, but it frequently provides a useful approximation and furthermore its structure 
is informative since it springs from a physical view of the behavior of gas molecules. 
For such a model there is no need to ask the question ‘Is the model true?’. If ‘truth’ is to be 
the ‘whole truth’ the answer must be ‘No’. The only question of interest is ‘Is the model illu-
minating and useful?’.” 
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[8]  ABSTRACT 
II ABSTRACT 
Antipsychotic drugs are highly effective in reducing positive symptoms of psychosis. However, 
despite major efforts, negative and cognitive symptoms are still not sufficiently treatable. Im-
portantly, these symptoms have been found to be strongly related to psychosocial functioning, 
thus emphasizing the urgent requirement of new treatments. Model systems are one ap-
proach to investigate underlying mechanisms of psychosis and aid the development of new 
treatments. 
In this thesis, I investigated the validity of schizotypy, a multidimensional attribute that includes 
positive, negative, and disorganized traits, and of sleep deprivation as model systems of psy-
chosis. Furthermore, I combined the two models to evaluate potential interactions between 
them. In order to validate cognitive performance alterations in schizotypy and after sleep dep-
rivation, I applied widely studied oculomotor biomarkers of psychosis (i.e. smooth pursuit eye 
movements and antisaccades). To evaluate the usefulness of oculomotor biomarkers as time 
stable cognitive patterns, I additionally conducted a study on the trait-like nature of saccadic 
tasks. 
The first part of the thesis deals with the research background of psychotic disorders, the foun-
dation of schizotypy and sleep deprivation as valuable model systems, and an introduction to 
widely studied oculomotor biomarkers of psychosis. The following chapter is a description with 
introductory information about the methods that I have deployed in the empirical studies. 
These methods include the recording and analysis of eye movements, latent state-trait mod-
eling, and functional magnetic resonance imaging. Following the presentation of the main find-
ings of the empirical studies, the thesis closes with an integration of the results in the present 
research literature and with indications to limitations of the studies and ideas for future re-
search. 
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III ZUSAMMENFASSUNG 
Antipsychotika sind wirksam in der Behandlung von Positivsymptomen der Psychose. Nega-
tivsymptome und kognitive Symptome sind trotz größter Bemühungen immer noch nicht zu-
friedenstellend behandelbar. Da die negativen und kognitiven Symptome eng mit dem psycho-
sozialen Funktionsniveau zusammenhängen, werden dringend neue Behandlungsmöglichkei-
ten gebraucht. Modellsysteme stellen einen vielversprechenden Ansatz dar, um zugrunde lie-
gende Mechanismen der Psychose zu untersuchen und die Entwicklung von neuen Behand-
lungsmöglichkeiten zu unterstützen. 
In der folgenden Dissertation habe ich die Validität von Schizotypie, einem multidimensionalen 
Persönlichkeitsmerkmal aus positiven, negativen und desorganisierten Eigenschaften und von 
Schlafentzug als mögliche Modellsysteme der Psychose untersucht. Außerdem habe ich diese 
beiden Modellsysteme in einer Studie kombiniert, um Interaktionen zwischen ihnen zu erfor-
schen. Zur Validierung der Veränderung von kognitiven Prozessen in hoch schizotypen Proban-
den und nach Schlafentzug habe ich bekannte okulomotorische Biomarker der Psychose ein-
gesetzt (glatte Augenfolgebewegungen, Antisakkaden). Um die Nützlichkeit von okulomotori-
schen Biomarkern als reliable kognitive Muster zu evaluieren, habe ich außerdem eine Studie 
zur Zeitstabilität von Sakkaden durchgeführt. 
Im ersten Teil der Dissertation werden der Forschungshintergrund zu psychotischen Störungen 
und die Grundlagen von Schizotypie und Schlafentzug als Modellsysteme vorgestellt, sowie ein 
Überblick zu den wichtigsten okulomotorischen Biomarkern der Psychose gegeben. Im folgen-
den Kapitel werden die empirischen Methoden vorgestellt, die in den Studien eingesetzt wor-
den sind. Diese Methoden umfassen die Aufzeichnung und Auswertung von Augenbewegun-
gen, Latent-State-Trait Analysen und funktionelle Kernspintomographie. Nach der Darstellung 
der Hauptbefunde werden die Studienergebnisse in der Diskussion in die bisherige Literatur 
eingeordnet und es werden Limitationen und Ideen für Folgestudien vorgestellt.  
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IV INTRODUCTION 
IV.I Model systems of psychosis 
IV.I.I Schizophrenia and the psychosis spectrum 
“The concept of schizophrenia only covers the 30% poor outcome fraction of a much broader 
multidimensional psychotic syndrome, yet paradoxically has become the dominant prism 
through which everything ‘psychotic’ is observed […].” 
[Guloksuz & Van Os, 2017; page 1] 
 
Psychotic disorders have a lifetime prevalence of about 3.5% (Perälä et al., 2007) and are 
among the third most expensive brain disorders in Europe with costs of approximately €93 
billion per year (DiLuca & Olesen, 2014; Olesen, Gustavsson, Svensson, Wittchen, & Jönsson, 
2012). Importantly, two thirds of the costs arise from indirect costs (e.g., lost productivity, so-
cial security), mirroring the high rate of unemployment amongst patients with psychosis 
(Evensen et al., 2016; Olesen et al., 2012). In addition to low employment, further serious 
problems result from poor social functioning, high rates of physical health problems, and lack 
of stable housing (Morgan et al., 2017). 
According to the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM 
5; American Psychiatric Association, 2013), key features of the schizophrenia spectrum and 
other psychotic disorders include delusions, hallucinations, disorganized thinking and motor 
behavior, and negative symptoms (e.g., diminished emotional expression, avolition, anhe-
donia). Additionally, cognitive deficits are common and appear to play an important role in the 
functional outcome (Barch et al., 2013; Heckers et al., 2013). 
However, although only 30% of the people that meet the criteria of a psychotic disorder suffer 
from schizophrenia (Perälä et al., 2007), schizophrenia is far more investigated than the other 
categories and is often suggested to represent a distinct genetic brain disorder (Van Os, 2016). 
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Therefore, most of the research presented in the current thesis is based on patients with schiz-
ophrenia. Nevertheless, there are many reports of psychotic symptoms across diagnostic cat-
egories (Mancuso et al., 2015; Murray et al., 2004) as well as the general population (Linscott 
& Van Os, 2013; Van Os, Linscott, Myin-Germeys, Delespaul, & Krabbendam, 2009), which 
question the concept of schizophrenia as a distinct entity and request the conceptualization of 
a psychosis spectrum ranging from mild symptoms to severe schizophrenia (Guloksuz & Van 
Os, 2017). Following this rationale, the results of the current thesis are embedded into the 
context of the spectrum of psychotic disorders. 
 
IV.I.II Model systems and their benefits 
Antipsychotic drugs constitute the main approach in the treatment of psychotic features in 
schizophrenia and other psychotic disorders and they are very effective in reducing positive 
symptoms such as hallucinations and delusions (Dunlop & Brandon, 2015; Jann, 2014; Köster, 
Carbon, & Correll, 2014; Rothschild, 2013; Sommer et al., 2012). However, despite major ef-
forts in the development of new compounds, negative and cognitive symptoms are still not 
sufficiently treatable (Chou, Twamley, & Swerdlow, 2012; Hill, Bishop, Palumbo, & Sweeney, 
2010; Keefe et al., 2013; Köster et al., 2014; Nielsen et al., 2015; Remington et al., 2016). Im-
portantly, these symptoms have been found to be strongly related to various social outcome 
variables (Chang, Hui, Chan, Lee, & Chen, 2016; Green, 2016; Rabinowitz et al., 2012), which 
underlines the urgent requirement of new treatments. 
A substantial problem in the development of new drugs is the high attrition rate due to lack of 
efficiency in clinical phase 2 (Breier, 2005; Kola & Landis, 2004). Thus, one impactful approach 
in further the understanding of the pathophysiology of psychosis and in identifying new drugs 
that are likely to succeed in clinical phase 2 is to create a condition resembling psychosis adding 
to clinical phase 1, e.g., using model systems. These model systems lack the confounds related 
to patient research and might be helpful in informing expensive clinical trials in phase 2 
(Carpenter & Koenig, 2008; Koychev et al., 2012). 
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As has been argued elsewhere “[the] ideal model of schizophrenia would faithfully mimic the 
biological changes driving pathogenesis and carry high predictive value for the efficacy of novel 
therapeutics” (Steeds, Carhart-Harris, & Stone, 2015). In order to attain this goal, many differ-
ent model systems have been developed (for an overview with examples see Table IV—1). 
 
Table IV—1.Overview of psychosis model systems 
Human models 
Surrogate populations  Schizotypy (Barrantes-Vidal, Grant, & Kwapil, 2015) 
 Low performers (Vollenweider, Barro, Csomor, & Feldon, 2006) 
Pharmacology Amphetamine (Bramness et al., 2012) 
 Cannabis (Koethe, Hoyer, & Leweke, 2009) 
 Lysergic Acid Diethylamide (De Gregorio, Comai, Posa, & Gobbi, 2016) 
 Ketamine (Javitt, Zukin, Heresco-Levy, & Umbricht, 2012) 
Deprivation Sleep deprivation (Ettinger & Kumari, 2015) 
 Sensory deprivation (Daniel, Lovatt, & Mason, 2014) 
Animal models 
Development Social isolation (Marsden, King, & Fone, 2011) 
Pharmacology Lysergic acid diethylamide (Halberstadt & Geyer, 2013) 
Lesions Ventral hippocampal lesion (Tseng, Chambers, & Lipska, 2009) 
Genetics Dopamine D1 receptor knockout mice (Van Den Buuse, 2010) 
 
Generally, these model systems can be subdivided into long-term trait (e.g., surrogate popula-
tions) and short-term state (e.g., pharmacological and experimental interventions) models. 
However, psychotic disorders are heterogeneous and complex and thus several limitations 
have been expressed concerning pharmacological model systems, e.g., receptor tautology 
(Geyer, Olivier, Joëls, & Kahn, 2012) and limited phenomenological specificity for negative or 
cognitive symptoms (Carhart-Harris, Brugger, Nutt, & Stone, 2013). Furthermore, animal 
model systems are valuable and have widely been applied in the preclinical phase of pro-cog-
nitive drug development for schizophrenia but their success has been limited so far (Burrows 
& Hannan, 2016; Mao, Cui, Zhao, & Ma, 2015; Pratt, Winchester, Dawson, & Morris, 2012; 
Young & Geyer, 2015). Therefore, systematic validation of additional model systems is needed. 
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Here, I will focus on schizotypy as a trait and sleep deprivation as a non-pharmacological hu-
man state model system. These may provide new insights into the underlying mechanisms of 
psychotic disorders and could be helpful to further the development of effective treatments. 
 
IV.I.III Schizotypy as a trait model of psychosis 
“She reports having a consistently ‘uneasy’ feeling when around others […]. She has experi-
enced herself as ‘different from others’ for as long as she can remember […]. She often feels 
that numbers, symbols, and certain images are imbued with a magical power of sorts […]. 
When walking down the street, she is especially attentive to the expressions on the faces of 
those who pass her. To her, a smile on the face of a stranger is often taken to mean that the 
stranger knows something about her […].” 
[Lenzenweger, 2010; pages 6-7] 
 
Schizotypy refers to temporally stable (Chan et al., 2015; Gross, Silvia, Barrantes-Vidal, & 
Kwapil, 2015; Venables & Raine, 2015) and multidimensional personality traits. There is broad 
agreement that schizotypal traits can be assigned to positive (e.g., unusual perceptual experi-
ences, ideas of reference), negative (e.g., dislike of emotional and physical intimacy, lack of 
enjoyment from social sources), and disorganized (e.g., odd speech, eccentric behavior) factors 
(Mason, Claridge, & Jackson, 1995; Raine et al., 1994). The factors were found to be invariant 
across cultures (Chan et al., 2015, 2016; Fonseca-Pedrero et al., 2015; Yu, Bernardo, & Zaroff, 
2016), time (Venables & Raine, 2015), sex (Fonseca-Pedrero, Paíno, Lemos-Giráldez, Sierra-
Baigrie, & Muñiz, 2011; Fossati, Raine, Carretta, Leonardi, & Maffei, 2003; Reynolds, Raine, 
Mellingen, Venables, & Mednick, 2000), and age (Bora & Baysan Arabaci, 2009; Fonseca-
Pedrero et al., 2011). However, the number of factors also depends on the measure of schizo-
typy, e.g., yielding only positive and negative schizotypy factors in some of the instruments 
(Gross et al., 2015; Kwapil, Barrantes-Vidal, & Silvia, 2008) and additional factors in others 
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(Davidson, Hoffman, & Spaulding, 2016; Gross, Mellin, Silvia, Barrantes-Vidal, & Kwapil, 2014; 
Stefanis et al., 2004). 
There are many different self-report and interview instruments that capture the construct of 
schizotypy (for overviews refer to Fonseca-Pedrero et al., 2008; Kwapil & Chun, 2015; Mason, 
2015; Vollema & Van den Bosch, 1995). The most widely used measurements represent the 
Schizotypal Personality Questionnaire (SPQ; Cohen, Matthews, Najolia, & Brown, 2010; 
Davidson et al., 2016; Raine, 1991; Raine & Benishay, 1995; Wuthrich & Bates, 2005), the Chap-
man Scales (Chapman, Chapman, & Raulin, 1976, 1978; Eckblad & Chapman, 1983; Winterstein 
et al., 2011), and the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE; Grant et 
al., 2013; Mason & Claridge, 2006; Mason et al., 1995; Mason, Linney, & Claridge, 2005). Most 
importantly, these different instruments were found to substantially correlate with each other, 
emphasizing the measurement of one underlying construct (Asai, Sugimori, Bando, & Tanno, 
2011; Gross et al., 2014; Rössler et al., 2015; Venables & Raine, 2015). 
The distribution of schizotypy in the population can be described by two competing models 
(Kwapil & Barrantes-Vidal, 2015). The first model, proposed by Meehl (1962, 1989, 1990), in-
spired by Rado (1953), and further pursued by Lenzenweger (2006, 2010), assumes schizotypy 
to represent a qualitative latent construct that is either present or absent. Meehl (1990) ar-
gued that about 10% of the population is afflicted by schizotaxia, an anomaly of the central 
nervous system caused by the schizogene, that almost always leads to a schizotypal personal-
ity. The second model, developed by Claridge and colleagues (Claridge, 1972, 1987; Claridge & 
Beech, 1995; Claridge & Broks, 1984), based on the ideas of Eysenck (Eysenck, 1967; Eysenck 
& Eysenck, 1968), argues that schizotypy constitutes a fully dimensional trait that is continu-
ously distributed in the population. Taxometric analyses provide an ongoing discussion about 
the distribution of schizotypy across the general population (Beauchaine, Lenzenweger, & 
Waller, 2008; Everett & Linscott, 2015; Linscott, 2013; Rawlings, Williams, Haslam, & Claridge, 
2008a, 2008b). However, the fully dimensional model was found to be superior to the quasi-
dimensional view in the explanation of various recent findings on schizotypy and schizophrenia 
(Grant, Munk, Kuepper, Wielpuetz, & Hennig, 2015; Nelson, Seal, Pantelis, & Phillips, 2013) but 
the issue has not been resolved (Lenzenweger, 2015; Mason, 2014). 
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Overlap between schizotypy and psychosis has been found on different levels of measurement 
(Barrantes-Vidal et al., 2015). The three factors of schizotypy resemble the factors previously 
found in schizophrenia (Liddle, 1987) and factor analyses revealed similar underlying structures 
of schizotypy in schizophrenia patients and healthy controls (Chan et al., 2016; Rossi & 
Daneluzzo, 2002). Additionally and in accordance with the psychosis spectrum, schizotypal 
traits were also found to be elevated not only in schizophrenia but also in patients with bipolar 
disorder (Brosey & Woodward, 2015; Chan et al., 2016; Cochrane, Petch, & Pickering, 2010; 
Dembińska-Krajewska & Rybakowski, 2016; Heron et al., 2003; Rossi & Daneluzzo, 2002). Fur-
thermore, there is evidence for genetic overlap (Walter, Fernandez, Snelling, & Barkus, 2016; 
however see Stefanis et al., 2007), shared cognitive deficits (Giakoumaki, 2012; Siddi, Petretto, 
& Preti, 2017; however see Chun, Minor, & Cohen, 2013), and similar deviations in brain struc-
ture and function (Ettinger et al., 2015) for high schizotypes and patients with schizophrenia. 
Together, these findings suggest that schizotypy shares many common features with clinical 
psychosis in an attenuated form, emphasizing its usefulness as a model system of psychosis.  
Studying schizotypy as a model system provides the advantage to examine underlying mecha-
nisms of psychosis without disruptive effects of clinical illness, medication, and hospitalization 
(Lenzenweger, 2010). Furthermore, conversion rates in high schizotypes were reported to be 
low (Chapman, Chapman, Kwapil, Eckblad, & Zinser, 1994; Gooding, Tallent, & Matts, 2005). 
Thus, as a trait model, schizotypy offers the possibility to image mechanisms of vulnerability 
rather than the symptomatic state (Koychev et al., 2011). Schizotypal traits vary in the normal 
population (Nelson et al., 2013) and can be assessed using self-report instruments that are 
cheap, reliable, and easy to administer (Kwapil & Chun, 2015; Mason, 2015). Therefore, schizo-
typy provides a relatively easy available opportunity to study the pathophysiology of psychosis 
and to support the development of new treatments. 
  
[16]  INTRODUCTION 
IV.I.IV Sleep deprivation as a state model of psychosis 
“I spent like 10 days sleeping 4 or even just 2 hours, and sometimes not at all. It was sunday 
and I felt uncredibly well. I did not sleep, or slept only 2 hours...and so, monday I got crazy. 
[…]... then my mind climbed, climbed... I had deliriums, I would be the new president... then I 
was taken to the hospital believing and saying the most crazy things. A doctor gave me an 
injection and I finally got asleep.” 
[M. G., personal communication, 2017] 
 
Randy Gardner’s experience of 11 days (264 hours) of sleep deprivation is one of the most 
cited records of long-term wakefulness (Coren, 1998; Ross, 1965). Symptoms of sleep depriva-
tion began with difficulty focusing the eyes (day 2) and moodiness (day 3). Hallucinations (mis-
took a street sign for a person) and a first delusional episode (imagined he was a famous foot-
ball player) followed on day 4 and, together, with fragmented thinking and memory lapses, 
these experiences became worse until day 11 (Coren, 1998; Ross, 1965). The symptoms were 
reversible with no physical or mental problems persisting after Gardner had slept again (Coren, 
1998). 
In addition to Randy Gardner and similar individual case reports, scientific researchers became 
interested in systematically investigating the effects of sleep deprivation on cognitive and psy-
chological variables. Early studies used descriptive impressions to characterize the conse-
quences of acute sleep deprivation. They found prolonged wakefulness with durations of 90 
to 205 hours to evoke experiences similar to hallucinations (smoke issuing from under 
doors/the walls/objects, humming or ringing noises in the ears, voices while a water tap was 
running, tingling sensations in the skin), to delusional thinking (feeling threatened by the fellow 
participants), and to negative (disinterest in the outside world, tendency to withdraw) and dis-
organized (overt confusion, disorientation, odd speech) psychosis symptoms (Berger & 
Oswald, 1962; Heinemann, 1966; Kales et al., 1970; Kollar et al., 1969; Luby et al., 1962; Patrick 
& Gilbert, 1896). 
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Later studies applied rating scales (Scott, McNaughton, & Polman, 2006) and validated psycho-
logical inventories (Kahn-Greene, Killgore, Kamimori, Balkin, & Killgore, 2007; Killgore et al., 
2008) to explore the effects of sleep deprivation. Those studies detected higher paranoia 
(Kahn-Greene et al., 2007) and greater confidence in formal superstitions and magical thinking 
processes (Killgore et al., 2008), as well as higher depressed mood (Kahn-Greene et al., 2007; 
Scott et al., 2006) and reduced positive thinking (Killgore et al., 2008). In addition to experi-
mental induced sleep deprivation, sleep dysfunctions, e.g., symptoms of insomnia, were also 
found to be associated to increases of psychotic experiences (Barton, Varese, Jones, Kyle, & 
Haddock, 2017; Reeve, Emsley, Sheaves, & Freeman, 2017). 
Beside alterations in mental states, sleep deprivation was reported to induce cognitive deficits 
such as reduced attention, working memory, and processing speed (Koslowsky & Babkoff, 
1992; Lim & Dinges, 2010; Phillips, 2005; Pilcher & Huffcutt, 1996) that are accompanied by 
widespread changes in brain function (Krause et al., 2017) and overlap with those seen in pa-
tients with psychotic disorders (Fatouros-Bergman, Cervenka, Flyckt, Edman, & Farde, 2014; 
Hill et al., 2013; Reichenberg & Harvey, 2007; Schaefer, Giangrande, Weinberger, & Dickinson, 
2013). 
There is an ongoing debate in the literature about the underlying mechanisms of the sleep 
deprivation induced cognitive deficits (Jackson et al., 2013; Lim & Dinges, 2010). On the one 
hand, fundamental attentive processes were emphasized to be responsible for the cognitive 
dysfunctions being present specifically in monotonous tasks. These hypotheses stress lapses 
(Williams, Lubin, & Goodnow, 1959), state instability (Doran, Van Dongen, & Dinges, 2001), 
less controlled attention (Pilcher, Band, Odle-Dusseau, & Muth, 2007), and reduced arousal 
(Wilkinson, 1961) and vigilance (Lim & Dinges, 2008) as relevant factors to explain cognitive 
impairments after sleep loss. On the other hand, Harrison, Horne and colleagues (Harrison, 
Horne, & Rothwell, 2000; Horne, 2000; Horne, 1993; Jones & Harrison, 2001) argue that sleep 
deprivation impacts on higher-order cognitive tasks that are mediated through the prefrontal 
cortex such as language (Harrison & Horne, 1998) and decision making (Harrison & Horne, 
2000) tasks, analogous to a healthy ageing condition (Harrison et al., 2000; Zhou, Wu, Yu, & 
Lei, 2017; however see Tucker, Stern, Basner, & Rakitin, 2011). To date, there are findings that 
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point to more integrative approaches, suggesting that cognitive decline through prolonged 
wakefulness is a result of both a reduction of attentional arousal and impaired central pro-
cessing (Boonstra, Stins, Daffertshofer, & Beek, 2007; Ratcliff & Van Dongen, 2009). 
Additionally, various characteristics and systematic interindividual differences seem to affect 
how people respond to long-term wakefulness (Van Dongen, Baynard, Maislin, & Dinges, 
2004), e.g., age (Brendel et al., 1990; Philip et al., 2004; Smulders, Kenemans, Jonkman, & Kok, 
1997; Webb, 1985), sex (Corsi-Cabrera, 2003), genetic variation (Dissel et al., 2015; Holst et al., 
2017), perceived sleep quality (Cosgrave et al., 2017), and personality (Killgore, Richards, 
Killgore, Kamimori, & Balkin, 2007; Rupp, Killgore, & Balkin, 2010; Taylor & McFatter, 2003). 
Interestingly, evidence for further amplifying factors on the impact of sleep deprivation was 
found in early studies investigating the effects of psychotomimetic drugs after prolonged 
wakefulness (Bliss, Clark, & West, 1959; Safer, 1970a, 1970b). Safer studied the effects of ly-
sergic acid diethylamide (1970b) and scopolamine (1970a) and found stronger cognitive im-
pairments and intense hallucinations in the combined drug sleep deprivation groups than the 
drug alone groups. 
Disturbances of sleep are common in schizophrenia patients (Freeman, Pugh, Vorontsova, & 
Southgate, 2009; Monti & Monti, 2004; Reeve et al., 2017) and symptoms appear to deterio-
rate under acute sleep deprivation (Koranyi & Lehmann, 1960). Emphasizing the association 
between sleep disruption, psychosis symptoms, and cognitive dysfunctions from a clinical per-
spective, sleep dysfunctions seem to be related to the severity of symptoms (Xiang et al., 2009) 
and poor cognitive functioning in schizophrenia patients (Ferrarelli, 2015; Wilson & 
Argyropoulos, 2012). 
Using sleep deprivation to model psychosis symptoms offers some crucial benefits (for an 
overview see Ettinger & Kumari, 2015) to existing models. Sleep deprivation is inexpensive, 
easy to apply, and can be considered as a safe model system as effects have been found to be 
completely reversible (Everson, 1997). Additionally, prolonged sleep can be combined with 
nearly any biomarker and can be applied cross-species (Frau et al., 2008).  
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IV.II Biomarkers and their application in psychosis research 
IV.II.I Definition and delimitation 
Biological markers, mostly abbreviated as biomarkers, represent characteristics that are “ob-
jectively measured and evaluated as indicators of normal biological processes, pathogenic pro-
cesses, or pharmacological responses to a therapeutic intervention” (Biomarkers Definitions 
Working Group, 2001). 
In clinical applications, biomarkers are proposed to be helpful with regard to diagnostic (clas-
sification of the presence of a disorder), prognostic (prediction of the development of a disor-
der), and theranostic (prediction of the response to a certain treatment) purposes (Weickert, 
Weickert, Pillai, & Buckley, 2013). Additionally, in scientific research contexts, biomarkers are 
beneficial in the development and evaluation of model systems (Ettinger & Kumari, 2015) and 
drug treatments (De Visser, Van der Post, Pieters, Cohen, & Van Gerven, 2001; Green, 
Nuechterlein, et al., 2004). Due to their objective measurement they can circumvent the prob-
lems of subjectivity and variability that are common in traditional measures such as rating 
scales and interviews (Koychev et al., 2011; Weickert et al., 2013). Thus, biomarkers might 
constitute a valuable addition to clinical ratings and interviews (Bender, Weisbrod, & Resch, 
2007). 
To achieve these goals, a biomarker must be closely associated to a given disorder. In practical 
terms, a biomarker should be an accurate indicator of the development, the presence or the 
progression of a specific disorder. Thus, biomarkers can represent persistent deviations, they 
can occur episodic and symptom-related, or they can be sequelae of the existing disorder 
(Thibaut et al., 2015). In other words, biomarkers can refer to altered behavioral and biological 
processes that are associated to the core of a disorder (trait biomarkers) or mirror the status 
of clinical symptoms (state biomarkers) (Chen, Bidwell, & Norton, 2006). Both, trait and state 
biomarkers can in principle be addressed by pharmacological compounds. However, modula-
tion of trait biomarkers should be independent from symptom alterations (Chen et al., 2006). 
When using biomarkers in the context of drug development, a consistent response across spe-
cific drugs with a clear response to a therapeutic dose and a dose-response relationship are 
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required. Additionally, a comprehensible association between the biomarker, the drug phar-
macology, and the pathogenesis of the disorder should be obtained (De Visser et al., 2001). 
Furthermore, test-retest reliability and the utility as a repeated measure are key elements of 
biomarkers that can be applied in clinical trials (Nuechterlein et al., 2008). 
Biomarker is often used as an umbrella term that comprises further concepts such as endo-
phenotypes. Endophenotypes, also referred to as intermediate phenotypes, can be considered 
as a subset of biomarkers that additionally meet the criteria of heritability and co-segregation 
(Glahn et al., 2014; Gottesman & Gould, 2003; Gould & Gottesman, 2006; for reviews of the 
endophenotype rationale and current scientific issues see Braff, 2015; Braff, Greenwood, 
Swerdlow, Light, & Schork, 2008; Flint & Munafò, 2007; Glahn et al., 2014; Gould & Gottesman, 
2006; Insel & Cuthbert, 2009). As the aim of the present thesis does not involve findings on 
genetic alterations or results from non-affected family members, the preferably used term 
here is considered to be biomarker. 
 
IV.II.II Importance of cognitive biomarkers 
“[…] cognitive deficits of schizophrenia are a core feature of the illness. A core feature means 
that the cognitive performance deficits are not simply the result of the symptoms, nor of the 
current treatments of schizophrenia. Instead, these deficits represent a fundamental aspect 
of the illness.” 
[Green et al., 2004; page 302] 
 
Generally, there is a broad literature on many different types of biomarkers that have been 
found to be relevant in schizophrenia research, e.g., neuropsychological, neurophysiological, 
neuroendocrine, and neuroimmune assessments (for overviews refer to Allen, Griss, Folley, 
Hawkins, & Pearlson, 2009; De Visser et al., 2001; Goff et al., 2016; Greenwood et al., 2016; 
Lai et al., 2016; Rodrigues-Amorim et al., 2017; Schmitt, Martins-de-Souza, et al., 2016; 
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Schmitt, Rujescu, et al., 2016; Stöber et al., 2009; Thibaut et al., 2015; Tomasik, Rahmoune, 
Guest, & Bahn, 2016). 
However, as cognitive dysfunctions are very common in schizophrenia (Aquila & Citrome, 
2015; Bhattacharya, 2015; Fioravanti, Carlone, Vitale, Cinti, & Clare, 2005; Heinrichs, 2004; 
Palmer, Dawes, & Heaton, 2009; Schaefer et al., 2013) and the broader psychosis spectrum 
(Reilly & Sweeney, 2014) and can still not be treated effectively (Keefe et al., 2013; Nielsen et 
al., 2015; Vingerhoets, Bloemen, Bakker, & Van Amelsvoort, 2013), biomarkers of cognition are 
particularly valuable in the research of new treatment options. Impairments of cognition were 
found to play a key role in schizophrenia and represent a much discussed topic among experts 
in the field (Keefe et al., 2015). Additionally, in order to advance treatment approaches, there 
is strong effort to develop suitable measures of cognitive processes (Carter & Barch, 2007; 
Green, Nuechterlein, et al., 2004; Nuechterlein et al., 2008).  
Cognitive impairments in schizophrenia include e.g., deficits of processing speed, attention, 
working memory, and executive functioning (Schaefer et al., 2013). Some of the dysfunctions 
are already present before the manifestation of the illness, e.g., in subjects with clinical high 
risk to develop psychosis (Bora & Murray, 2014; Seidman et al., 2016) and remain relatively 
stable from the first episode over the course of the illness (Bergh et al., 2016; Ekerholm et al., 
2012; Hoff, Svetina, Shields, Stewart, & DeLisi, 2005; Rund et al., 2016). Additionally, cognitive 
deficits have been found regardless of drug treatment, e.g., in medication naïve first episode 
patients (Fatouros-Bergman et al., 2014) and relatively independent from remission of clinical 
symptoms (Bergh et al., 2016; Braw et al., 2013; Heilbronner, Samara, Leucht, Falkai, & Schulze, 
2016). Impairments in cognition do not only relate to schizophrenia but also to the psychosis 
spectrum (Bora & Pantelis, 2015; Bora, Yucel, & Pantelis, 2010; Hill et al., 2013; Kuswanto et 
al., 2016; Lewandowski, Cohen, & Ngur, 2011; Reichenberg et al., 2009; Trotta, Murray, & 
MacCabe, 2015). In order to account for the important role of cognitive impairments, the latest 
version of the DSM has included a dimensional assessment of cognitive impairments in the 
psychotic disorders section (Barch et al., 2013). 
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Most importantly and emphasizing its impact as a treatment goal, numerous findings have 
demonstrated that cognitive impairments are associated to psychosocial functioning, out-
come, and relapse (Chang et al., 2016; Chen et al., 2005; Fervaha, Foussias, Agid, & Remington, 
2014; Green, 1996; Green, Kern, Braff, & Mintz, 2000; Green, Kern, & Heaton, 2004; 
Nuechterlein et al., 2011). Widely used measures to display cognitive functioning in patients 
represent neuropsychological tests (e.g., MATRICS Consensus Cognitive Battery; Nuechterlein, 
Green, et al., 2008) that through their complexity may have problems to detect subtle effects 
of pharmacological treatments (Reilly & Sweeney, 2014). In contrast to neuropsychological 
tests, neurophysiological measures, e.g. prepulse inhibition (PPI) and oculomotor measures, 
are far more specific and may therefore be advantageous in evaluating pharmacological alter-
ations in cognitive functioning (Green et al., 2009; Hill et al., 2010; Reilly, Lencer, Bishop, Keedy, 
& Sweeney, 2008). 
 
IV.II.III Oculomotor biomarkers 
i. Foundations and oculomotor tasks 
“The oculomotor system is a microcosm of the brain -it has sensory input, motor output, and 
incorporates bits of virtually all the major anatomical structures. In clinical neurological prac-
tice, few diagnostic tests discover quite so much quite so quickly as a test of oculomotor func-
tion.” 
[Carpenter, 1994; page 341] 
 
Foundations 
Measuring oculomotor control offers some crucial benefits in the assessment of cognitive func-
tions and there has been much progress with many new insights in the last decades. The pro-
gress involves technical advances of oculomotor measure methods (Duchowski, 2007) and a 
lot of practical research on eye movements (Klein & Ettinger, 2008; Kowler, 2011). 
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Generally, the assessment of oculomotor variables offers a tool to study cognitive functions 
using highly selective measures and an efficient way as regards to time and personnel re-
sources. Mostly, oculomotor tasks are short and their instructions are straightforward (Klein & 
Ettinger, 2008). Thus, in accordance with the required criteria of tolerability and practicability 
(Green, Nuechterlein, et al., 2004), the assessment is relatively simple to implement and fea-
sible even in severely impaired patients (Poletti et al., 2017). Furthermore, oculomotor tasks 
can be adapted systematically to tap into different cognitive functions very specifically (Barnes, 
2008; Hutton, 2008). In addition, the neural underpinnings of the oculomotor systems are well-
understood as the use and combination of many different measurement methods have ad-
vanced this field, by applying e.g., lesion studies (Müri & Nyffeler, 2008; Sharpe, 2008), assess-
ments in non-human primates (Ilg & Thier, 2008; Johnston & Everling, 2008), and investigations 
using various imaging and electrophysiological methods in humans (Lencer & Trillenberg, 2008; 
McDowell, Dyckman, Austin, & Clementz, 2008). 
Another strength of measuring oculomotor function is the limited set of types of eye move-
ments that have different properties with regards to their role in vision and their physiological 
and anatomical characteristics. Leigh and Zee (2015) differentiate vestibular (keep images sta-
ble on the retina during brief rotations of the head), vergence (disjunctive eye movements to 
keep/place images on the fovea), optokinetic (keep images stable on the retina during sus-
tained rotations of the head), and smooth pursuit (SPEM; hold the image of a small moving 
object on the fovea) eye movements, fixations (hold images of a stationary object on the fo-
vea), quick phases of nystagmus (reposition the eyes during sustained rotation towards the 
oncoming scene), and saccades (cause objects of interest to be placed on the fovea). 
SPEM and saccades have been most widely studied in relation to cognitive and brain functional 
disturbances of patients with psychotic disorders. 
 
SPEM 
SPEM are a mechanism that allows to follow a small moving object solely with the eyes aiming 
to provide a clear vision of this object (Leigh & Zee, 2015). Two factors are important to attain 
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this goal (Barnes, 2008). First, as motion of the object’s image on the retina adversely affects 
visual acuity, retinal motion has to be minimized and retinal velocity error/retinal slip velocity 
(difference between target velocity and eye velocity) is used as sensory input to SPEM. Sec-
ondly, the fovea is the area of the retina with the highest acuity and, therefore, the image of 
the object should ideally be processed close to the fovea. Whenever position error is detected, 
small saccadic eye movements are used to realign the eyes (see Orban de Xivry & Lefèvre, 2007 
for further information on the collaboration network of pursuit and saccades). 
Saccadic eye movements that disrupt pursuit are divided into compensatory and intrusive sac-
cades (Levy, Sereno, Gooding, & O’Driscoll, 2010). Compensatory saccades reduce position er-
ror by repositioning the eyes on the target (catch-up saccades, back-up saccades). Intrusive 
saccades increase the position error of the eye by disturbing the correspondence between eye 
and target (anticipatory saccades, leading saccades, square wave jerks). A full description of 
the saccade types can be found in Chapter V.I. However, as opposed to saccades towards sta-
tionary stimuli, the programming involves not only the position error but also information 
about the target motion (De Brouwer, Missal, & Lefèvre, 2001). 
Generating SPEM can be divided into two successive phases (open-loop, closed-loop; 
Lisberger, Morris, & Tychsen, 1987). SPEM are initiated roughly 100ms after a stimulus has 
started to move (Robinson, 1965), presumably due to 70ms processing delay and 30ms initia-
tion time (Wyatt & Pola, 1987). The first 100ms pursuit were found to be guided by the per-
ception of target motion across the retina and do not depend on visual feedback comparable 
to an open-loop system (Lisberger & Westbrook, 1985). The initiation of pursuit can be inves-
tigated using ramp tasks or, in order to avoid the initial saccade that realign the image to the 
fovea, step-ramp tasks can be applied (Carl & Gellman, 1987; Rashbass, 1961). 
After 100ms, retinal slip velocity is deployed as a feedback control and the system works 
closed-loop (Lisberger et al., 1987), relying on retinal (slip velocity) and (after a short familiari-
zation period) extra-retinal (prediction, anticipation) input. The maintenance of pursuit is com-
monly studied with triangular or sinusoidal target movements. Thereby, stressing the impact 
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of predictive mechanisms, these periodic waveforms can be tracked more accurately than pre-
dicted from usually existing visual processing delays (Barnes, 2008). Findings that have exam-
ined the role of periodicity on prediction reported that unexpected changes to periodic wave-
forms result in poor adjustment to the novel waveform partly due to maintaining eye velocity 
consistent with the preceding waveform (Barnes & Asselman, 1991a, 1991b). Furthermore, 
the use of predictive and anticipatory functions has been explored using target occlu-
sion/blanking (for an overview see Fukushima, Fukushima, Warabi, & Barnes, 2013). SPEM can 
be sustained, albeit with lower accuracy, during short periods of target disappearance (Becker 
& Fuchs, 1985) and even recover when expecting the target to reappear (Bennett & Barnes, 
2003, 2004). Additionally, SPEM can be generated anticipatorily when the stimulus is blanked 
initially but reappears shortly afterwards (Barnes & Collins, 2008). 
Neural core regions of SPEM include (for overviews refer to Leigh & Zee, 2015; Lencer & 
Trillenberg, 2008) motion-sensitive area V5 (Dukelow et al., 2001; Mukherjee, Battifarano, 
Simoncini, & Osborne, 2015), frontal eye fields (Fukushima et al., 2002; Gagnon, Paus, 
Grosbras, Pike, & O’Driscoll, 2006; Rosano et al., 2002; Tanaka & Lisberger, 2001), supplemen-
tary eye fields (Gagnon et al., 2006; Lencer, Nagel, et al., 2004; Missal & Heinen, 2004; Schmid, 
Rees, Frith, & Barnes, 2001), and parietal eye fields (Lencer, Nagel, et al., 2004; Nagel et al., 
2006; Nagel, Sprenger, Hohagen, Binkofski, & Lencer, 2008; Schmid et al., 2001). 
Models based on control theory have made a major contribution to the specification of the 
dynamic characteristics and physiological foundations of SPEM (for overviews refer to Barnes, 
2008; Glasauer, 2007; Leigh & Zee, 2015; Lencer & Trillenberg, 2008). A key model proposed 
by Yasui and Young (1975) is based on the assumption that stable pursuit is obtained by the 
positive feedback of an efference copy (Von Holst & Mittelstaedt, 1950)/corollary discharge 
signal (Sperry, 1950) of the oculomotor command. According to this and similar models (e.g., 
Robinson, Gordon, & Gordon, 1986) the stimulus for SPEM is an internal representation com-
bining retinal slip velocity inferred from the retina and the efference copy of the motor com-
mand. However, the models cannot account for findings of e.g., recovery of eye velocity shortly 
before expected target reappearance (Bennett & Barnes, 2003, 2004). Therefore, more recent 
methods suggest to add a predictive pathway (second internal loop that stores information 
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about target velocity similar to a working memory; Fukushima, Fukushima, Warabi, & Barnes, 
2013) or use generative models that rely on active inference (sample sensory inputs in order 
to minimize errors of prediction; Adams, Perrinet, & Friston, 2012). 
The main dependent variables can be classified into global and specific measures (for an 
overview see Smyrnis, 2008). Global measures refer to the full recording of SPEM thus includ-
ing sections of pursuit as well as sections of saccadic eye movements. Therefore, using global 
measures (e.g., global error of eye compared to target position, root mean square error; RMSE) 
to evaluate SPEM yield no clear distinctions between possible inabilities either to pursue the 
target or to suppress the saccadic system (“abnormalities of pursuit” or “abnormalities during 
pursuit”; Abel & Ziegler, 1988). However, the RMSE was found to be highly valuable for quan-
tifying deficits in clinical populations (Clementz, Iacono, & Grove, 1996). Specific measures re-
fer either to the pursuit (e.g., velocity gain; how well does eye velocity match target velocity) 
or to the saccadic system (e.g., number of saccadic intrusions per second). A full description of 
the measures can be found in Chapter V.I. 
 
Prosaccades and antisaccades 
Prosaccades are visually-guided saccades that require the participant to look as fast and as 
accurately as possible towards a sudden-onset peripheral target (Figure IV—1). The cognitive 
influences on the generation of saccades can be illustrated using the LATER (Linear Approach 
to Threshold with Ergodic Rate) model proposed by Carpenter and colleagues (1981; 1995). 
Briefly summarized, there is a decision signal that increases from baseline with a certain rate 
until a threshold value is attained and the saccade is triggered. All model parameters can po-
tentially be affected by cognitive processes. Thus, these cognitive modulations can be respon-
sible for whether a saccade and how quickly this saccade is triggered (Hutton, 2008). In addi-
tion, the generation of a saccade always requires balancing bottom-up (e.g., stimulus position, 
size, luminance) and top-down (e.g., goals, intentions) signals (Hutton, 2008). 
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There is a strong association between saccade execution and attention. In their eye-mind as-
sumption, Just and Carpenter (1980) summarized the relationship as follows: “there is no ap-
preciable lag between what is being fixated and what is being processed” (page 331). Even 
though there is broad agreement that saccadic eye movements and spatial attention are 
closely linked to each other (Hutton, 2008), it remains unclear how to describe the relationship 
itself (e.g., overt and covert shifts of attention are functionally independent, Hunt & Kingstone, 
2003; they are loosely functionally connected, Fischer & Weber, 1993; or they are more explicit 
functionally relate, Schneider, 1995). 
In the antisaccade paradigm (Hallett, 1978), the participant is required to perform a saccade 
to the opposite direction of a sudden-onset peripheral target (Figure IV—1). Antisaccades typ-
ically result in a considerable proportion of direction errors (~20%), which in almost all cases 
(~99%) are immediately followed by a correct antisaccade (Hutton & Ettinger, 2006; Tatler & 
Hutton, 2007). Prosaccades are often used as a control condition in addition to antisaccades. 
They represent an elegant and convenient experimental control because both tasks share the 
same stimuli and they only differ in their task instructions (Hutton, 2008; Munoz & Everling, 
2004). Thereby, they can either be presented separately in blocks consisting only of prosac-
cades or antisaccades or in a mixed design with randomized alternating prosaccades and anti-
saccades (Cherkasova, Manoach, Intriligator, & Barton, 2002; Dyckman, Camchong, Clementz, 
& McDowell, 2007). Obtaining prosaccades in addition to antisaccades is strongly recom-
mended in clinical and experimental research (Antoniades et al., 2013) because prosaccade 
data are helpful to model antisaccades and allow to investigate whether performance impair-
ments are already present in low-level visuomotor control. 
The performance of correct antisaccades is thought to consist of two relevant processes: First, 
the automatic answer towards the peripheral target must be suppressed and second, the lo-
cation of the peripheral stimulus has to be transformed into a voluntary eye movement away 
from the target (Cutsuridis, 2017; Everling & Fischer, 1998; Hutton & Ettinger, 2006; Munoz & 
Everling, 2004). Thereby, previous findings suggest parallel saccade programming and a com-
petition between the exogenously elicited prosaccade and the endogenously activated anti-
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saccade starting at stimulus onset (Hutton & Ettinger, 2006; Massen, 2004). Thus active inhib-
itory processes have been proposed to represent key features in suppressing erroneous pro-
saccades and executing correct antisaccades (Crawford, Bennett, Lekwuwa, Shaunak, & 
Deakin, 2002; Hutton, 2008). Additional cognitive processes that are relevant to calculate ap-
propriate coordinates and initiate the correct antisaccade include working memory (Mitchell, 
Macrae, & Gilchrist, 2002) and goal activation (Nieuwenhuis, Broerse, Nielen, & Jong, 2004). 
Figure IV—1. Illustration of a correct performed prosaccade (left) and antisaccade (right). 
 
The neural saccade circuit comprises the primary visual and extra-striate cortices, regions of 
posterior parietal cortex, frontal and supplementary eye fields, striatum, thalamus, and the 
superior colliculus (Jamadar, Fielding, & Egan, 2013; McDowell et al., 2008). Generally, antisac-
cades have been shown to elicit more extended brain activation than prosaccades. Differences 
were most consistently found in parietal and dorsolateral prefrontal cortices and in frontal and 
supplementary eye fields (DeSouza, Menon, & Everling, 2002; Dyckman et al., 2007; Ettinger 
et al., 2008; for overvews refer to Cieslik, Seidler, Laird, Fox, & Eickhoff, 2016; Hutton & 
Ettinger, 2006; Jamadar, Fielding, & Egan, 2013; McDowell et al., 2008; Munoz & Everling, 
2004). However, task properties (block/mixed design) may play an important role in explaining 
divergent results regarding neural differences between prosaccades and antisaccades across 
studies (Dyckman et al., 2007). Additionally, variation in brain activation between prosaccades 
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and antisaccades was proposed to stem from preparatory and not from movement related 
differences (DeSouza et al., 2002). 
The main dependent variables for prosaccades and antisaccades (Antoniades et al., 2013; Leigh 
& Zee, 2015) include percentages of direction errors, latencies (time that is needed to start the 
saccade), accuracy measures (how accurate does the amplitude of the saccade match the am-
plitude of the target), and peak velocities. A full description of the measures can be found in 
Chapter V.I. 
 
ii. Oculomotor dysfunctions in psychosis 
“If one’s experience of the sensory consequences of one’s action was not attenuated, then 
when one made an active movement it would feel like a passive movement. It would feel as if 
one’s action was being driven by an external force.” 
[Fletcher & Frith, 2009; page 50] 
 
SPEM 
Diefendorf and Dodge showed in 1908 that patients with schizophrenia suffer from deterio-
rated SPEM (Diefendorf & Dodge, 1908). Nearly 70 years later, Holzman and colleagues repli-
cated these deficits (Holzman, Proctor, & Hughes, 1973). Since then numerous studies have 
been conducted on the performance of SPEM in schizophrenia and findings of impaired per-
formance have widely been replicated (for overviews refer to Franco, De Pablo, Gaviria, 
Sepúlveda, & Vilella, 2014; Hutton & Kennard, 1998; Levy, Holzman, Matthysse, & Mendell, 
1993, 1994; Levy, Sereno, Gooding, & O’Driscoll, 2010; O’Driscoll & Callahan, 2008; Tandon, 
1999; Thaker, 2000, 2008; Trillenberg, Lencer, & Heide, 2004). 
The most frequently reported deficit in schizophrenia patients is low maintenance gain (Bagary 
et al., 2004; Boudet et al., 2005; Fabisch et al., 2009; Haraldsson et al., 2008, 2009; Hutton et 
al., 2004; Ivleva et al., 2014; Kathmann, Hochrein, Uwer, & Bondy, 2003; Lencer et al., 2015; 
Lencer, Trillenberg, et al., 2004; Louchart-De La Chapelle et al., 2005; Morita et al., 2017; Nagel 
[30]  INTRODUCTION 
et al., 2007; Nkam et al., 2010; Spering, Dias, Sanchez, Schutz, & Javitt, 2013; Sprenger, 
Trillenberg, Nagel, Sweeney, & Lencer, 2013; Trillenberg et al., 2017). 
Furthermore, poor performance in schizophrenia has been detected using global measures 
such as reduced SPEM quality (Amador et al., 1991; Chen, Levy, et al., 1999), higher signal to 
noise ratio (Allen, 1997; Benson et al., 2012; Kelly et al., 1990), and increased global position 
error (Benson et al., 2012; Lee, Williams, Loughland, Davidson, & Gordon, 2001; Sponheim, 
Iacono, Thuras, Nugent, & Beiser, 2003; Sweeney et al., 1993). 
Additionally, schizophrenia patients demonstrate more frequent saccadic intrusions during 
SPEM (Allen, 1997; Campion et al., 1992; Haraldsson et al., 2008, 2009; Mather, Neufeld, 
Merskey, & Russell, 1992). More specifically, schizophrenia has been found to be associated to 
higher frequencies (Abel, Friedman, Jesberger, Malki, & Meltzer, 1991; Friedman et al., 1995; 
Lencer et al., 2008; Nkam et al., 2001) and amplitudes (Sweeney, Clementz, et al., 1994; 
Sweeney, Haas, Li, & Weiden, 1994) of catch-up saccades and higher rates of anticipatory 
(Friedman, Abel, Jesberger, Malki, & Meltzer, 1992; Ross, Olincy, Harris, Sullivan, & Radant, 
2000; Spengler et al., 2006; Sweeney et al., 1993) and leading (Martin et al., 2007; Ross et al., 
2002, 2000; Ross, Olincy, Harris, et al., 1999) saccades. No differences between patients and 
controls were reported for square wave jerks (Campion et al., 1992; Clementz, Sweeney, Hirt, 
& Haas, 1990; Flechtner, Steinacher, Sauer, & Mackert, 1997; Nkam et al., 2001; Sweeney et 
al., 1993) and back-up saccades (Litman, Hommer, Radant, Clem, & Pickar, 1994; Radant & 
Hommer, 1992). 
In addition to disturbed closed-loop SPEM, patients with schizophrenia display worse pursuit 
initiation (Chen, Levy, et al., 1999; Chen, Nakayama, Levy, Matthysse, & Holzman, 1999; Hong, 
Avila, Adami, Elliot, & Thaker, 2003; Lencer et al., 2010, 2015; Sweeney et al., 1999; Trillenberg 
et al., 2017) and reduced capacities of SPEM prediction during stimulus disappearance (Hong 
et al., 2003; Ivleva et al., 2014; Thaker, Ross, Buchanan, Adami, & Medoff, 1999; Trillenberg et 
al., 1998, 2017). 
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A comprehensive meta-analysis (O’Driscoll & Callahan, 2008) that summarized studies from 
1998 to 2008 (k=57, npatients=2049, ncontrols=1927) reported high effect sizes for global variables 
(d=0.70-1.55), maintenance gain (d=0.87), and leading saccade rate (d=1.31).  
Neural correlates of SPEM impairments in schizophrenia mainly comprise abnormal activation 
in frontal and occipital areas. Specifically, most studies have reported lower brain activity dur-
ing SPEM for schizophrenia patients compared to healthy controls in frontal and supplemen-
tary eye fields (Hong et al., 2005; Keedy, Ebens, Keshavan, & Sweeney, 2006; Tregellas et al., 
2004). In addition, impaired SPEM were found to be associated to reduced gray matter integ-
rity (Bagary et al., 2004) and lower metabolism (Ross et al., 1995) in frontal areas. However, 
there are also findings of SPEM related increased activations in dorsolateral prefrontal cortex 
and frontal eye fields in schizophrenia (Lencer et al., 2011; Nagel et al., 2007). Furthermore, 
patients with schizophrenia were found to exhibit abnormal brain activation in the motion-
sensitive V5 complex (Hong et al., 2005; Lencer, Nagel, Sprenger, Heide, & Binkofski, 2005; 
Nagel, Sprenger, Steinlechner, Binkofski, & Lencer, 2012). A recent study that combined SPEM 
recording with electroencephalography found schizophrenia patients to demonstrate reduced 
frontal/posterior phase synchronization in beta to gamma range frequency bands (Krishna, 
O’Neill, Sánchez-Morla, & Thaker, 2014). 
Emphasizing stability independent from clinical status, most studies revealed no significant as-
sociations between SPEM performance and severity of clinical symptoms (Haraldsson et al., 
2008; Hutton et al., 2004; Kallimani et al., 2009; Kelly et al., 1990; Lencer et al., 2008, 2015; 
Louchart-De La Chapelle et al., 2005; Schlenker et al., 1994) or differences between non-deficit 
and deficit schizophrenia patients (Nkam et al., 2001, 2010). However, some studies reported 
that higher SPEM deficits were modestly related to more pronounced (predominantly nega-
tive) schizophrenia symptoms (Hong et al., 2003; Lee et al., 2001; Lees Roitman, Keefe, Harvey, 
Siever, & Mohs, 1997; Malaspina et al., 2002; Ross et al., 1996, 1997; Sweeney, Clementz, et 
al., 1994). 
SPEM deficits have been assessed in chronic schizophrenia (Katsanis & Iacono, 1991; Litman et 
al., 1991), in the residual subtype (Arolt, Teichert, Steege, Lencer, & Heide, 1998), and in first 
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episode medicated (Bagary et al., 2004; Hutton et al., 1998, 2004; Keedy et al., 2006), un-
treated (Lencer et al., 2011; Rybakowski & Borkowska, 2002), and medication naïve (Keedy et 
al., 2006; Lencer et al., 2008; Sweeney, Haas, et al., 1994) patients. Some studies that com-
pared treated and untreated first episode and chronic patients reported rather similar SPEM 
disturbances in all patient groups compared to healthy controls (Campion et al., 1992; Hutton 
et al., 2001; Thaker et al., 1999). Additionally, SPEM have been found to be impaired in unaf-
fected first-degree relatives of schizophrenia patients (Lencer et al., 2015). In accordance with 
these findings, SPEM in schizophrenia patients were found to maintain stable over time 
(Benson et al., 2012; Calkins, Iacono, & Curtis, 2003; Lencer et al., 2010; Yee, Nuechterlein, & 
Dawson, 1998), despite improvement of clinical symptoms (Flechtner, Steinacher, Sauer, & 
Mackert, 2002; Gooding, Iacono, & Beiser, 1994; Kallimani et al., 2009; Schlenker & Cohen, 
1995) or commencement of medical treatment (Campion et al., 1992; Sweeney, Haas, et al., 
1994). Together, these findings of time stability, independence of clinical symptoms, and pres-
ence in unaffected first-degree relatives suggest SPEM impairments to represent a valuable 
trait biomarker of schizophrenia. 
Studies on the impacts of current available antipsychotic medication on SPEM performance in 
schizophrenia revealed either no/minimal (Flechtner et al., 2002; Sweeney et al., 1998; 
Sweeney, Haas, et al., 1994) or even adverse (Friedman, Jesberger, & Meltzer, 1992; Lencer et 
al., 2008; Litman et al., 1994) effects. More specifically, Hutton and colleagues (2001) found 
that SPEM gain was unaffected by short-term but deteriorated by long-term antipsychotic 
medication. 
Cognitive deficits that play an important role in the explanation of SPEM deficits in schizophre-
nia cover impairments in motion processing, prediction/anticipation, and attention. Facilita-
tion of attention during SPEM (monitor changes of the stimulus) revealed an improvement of 
overall performance in patients and controls (Amador et al., 1991; Cegalis & Sweeney, 1981; 
Schlenker et al., 1994; Sweeney, Clementz, et al., 1994; Sweeney, Haas, et al., 1994; however 
see Yee et al., 1998). These findings suggest that impairments of attentive processes do not 
constitute the primary reason of SPEM deficits in schizophrenia (Sweeney, Clementz, et al., 
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1994). In accordance with the rather subtle effects of attention enhancement on SPEM per-
formance in schizophrenia patients, Stuve and colleagues (1997) found a strong association 
between deteriorated SPEM and lower motion perception even after controlling for measures 
of attention. Additionally, underlining the responsibility of deficient motion perception, many 
studies have reported impairments of sensorimotor transformation in schizophrenia that are 
mostly reflected by reduced initial eye velocity/acceleration (Lencer et al., 2010, 2015; 
Trillenberg et al., 2017). With regard to higher cognitive functions, schizophrenia patients fail 
to adequately use efference copy/predictive (Spering et al., 2013) and anticipatory (Avila, 
Hong, Moates, Turano, & Thaker, 2006) information (however see Trillenberg et al., 2017). 
Furthermore, patients with schizophrenia were found to demonstrate difficulties maintaining 
SPEM during periods of blanking (Ivleva et al., 2014; Thaker et al., 1999; Trillenberg et al., 2017; 
however see Sprenger et al., 2013). The use of efference copy information to attenuate sen-
sory experiences is important in distinguishing self-generated from externally-generated ac-
tions. Adversely affected efference copy function was found to significantly contribute to ex-
planation approaches of psychosis symptoms (Feinberg, 1978; Ford & Mathalon, 2012; Pynn 
& DeSouza, 2013) and higher deficits were found to be associated to higher symptom severity 
in schizophrenia patients (Rösler et al., 2015). 
In agreement with the hypothesized overlap between different phenotypes of psychosis 
(Tamminga et al., 2013), SPEM deficits have been found to be present not only in schizophrenia 
but also in patients with schizoaffective (Martin et al., 2007) and affective (Ivleva et al., 2014; 
Kathmann et al., 2003; Lencer et al., 2010; Sponheim et al., 2003; Sweeney et al., 1999; 
Trillenberg et al., 2017) disorders. However, some findings concluded that impairments in 
schizophrenia were more severe compared to other disorders of the psychosis spectrum 
(Amador et al., 1991; Lencer et al., 2015; Lencer, Trillenberg, et al., 2004). Emphasizing diag-
nostic specificity to psychosis spectrum disorders, rather intact SPEM were found for patients 
with predominantly non-psychotic affective disorders (Abel et al., 1991; Fabisch et al., 2009; 
Friedman et al., 1995), substance use disorders (Kathmann, Wagner, Rendtorff, Schöchlin, & 
Engel, 1995; Radant & Hommer, 1992), and attention-deficit/hyperactivity disorder (Ross et 
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al., 2000). Additionally minimal or distinct deficits were reported in obsessive compulsive dis-
order (Damilou, Apostolakis, Thrapsanioti, Theleritis, & Smyrnis, 2016; Farber et al., 1997; 
Lencer et al., 2004; Spengler et al., 2006; for an overview see Jaafari et al., 2011) and posttrau-
matic stress disorder with secondary psychotic symptoms (Cerbone et al., 2003). 
In summary, many studies have replicated SPEM disturbances in schizophrenia patients 
(O’Driscoll & Callahan, 2008) and their neural correlates were found to comprise abnormal 
activation in frontal and motion-sensitive posterior areas (Hong et al., 2005; Nagel et al., 2012). 
These trait-like deficits remain stable over time (Benson et al., 2012), are rather independent 
from clinical symptoms (Lencer et al., 2015), pertain the further psychosis spectrum (Lencer et 
al., 2015), and the beneficial effects of current available medication is low (Lencer et al., 2008). 
Underlining its importance in every day functioning, impaired SPEM in schizophrenia patients 
were also found in natural settings (Dowiasch et al., 2016) and to be associated to reduced 
occupational and social functioning (Beiser et al., 1994; Katsanis, Iacono, & Beiser, 1996). 
 
Prosaccades and antisaccades 
In 1988, Fukushima and colleagues first detected disturbances in the control of antisaccades 
in schizophrenia patients (Fukushima et al., 1988). Since then, numerous studies have repli-
cated increased direction error rates (Ettinger et al., 2006; Ettinger, Kumari, Crawford, et al., 
2004; Haraldsson et al., 2008; Mazhari et al., 2011; Nkam et al., 2001; Radant et al., 2010, 
2015; Reilly et al., 2014), promoting antisaccades to be a highly valuable biomarker of schizo-
phrenia (Thibaut et al., 2015). Importantly, schizophrenia patients display normal error correc-
tion rates underlining adequate task understanding and intact error awareness (Nkam et al., 
2001; Polli et al., 2008). Thus, this finding emphasizes that the reasons for deteriorated anti-
saccade performance are associated to impairments in cognitive control mechanisms and not 
to deficient understanding of the task instructions or lack of motivational aspects. 
In addition to direction errors, schizophrenia patents were found to demonstrate prolonged 
latencies and reduced spatial accuracy (Haraldsson et al., 2008; Maruff, Danckert, Pantelis, & 
Currie, 1998; Mazhari et al., 2011; Radant et al., 2015; for an overview, see Gooding & Basso, 
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2008). When comparing schizophrenia patients and healthy controls in basic saccade genera-
tion, e.g., prosaccades, most studies agree that both groups display similarly intact perfor-
mance (Broerse, Crawford, & den Boer, 2001; Gooding & Basso, 2008). 
The neural correlates of antisaccade deficits in schizophrenia include dysfunctions in fronto-
striatal regions. Schizophrenia patients were found to demonstrate frontal cortical atrophy 
(Fukushima et al., 1988) and they fail to demonstrate higher brain activity in dorsolateral pre-
frontal cortex (Fukumoto-Motoshita et al., 2009; McDowell et al., 2002; Nakashima et al., 
1994) and further frontal regions (Tu, Yang, Kuo, Hsieh, & Su, 2006) during antisaccades, a 
neural pattern that is apparent in healthy controls. In addition to reduced activation of pre-
frontal cortex, Camchong and colleagues (2008) also detected lower brain signal during anti-
saccades for patients in frontal and supplementary eye fields, middle occipital gyrus, insula, 
cuneus, and anterior cingulate. Higher antisaccade direction errors were found to be associ-
ated to reduced grey matter volume in the medial superior frontal cortex (Bagary et al., 2004) 
and longer latencies of correct antisaccades were related to smaller prefrontal lobe volume in 
schizophrenia patients and healthy controls (Schulze et al., 2006). 
Recently, deficient antisaccade performance was suggested to be explained by an aberrant 
pattern in rostral and dorsal anterior cingulate cortices and ventrolateral prefrontal cortex dur-
ing the preparation of antisaccades (Manoach et al., 2013; Polli et al., 2008). Furthermore, 
associations between number of antisaccade errors and activation of anterior cingulate corti-
ces were less pronounced in patients than controls (Polli et al., 2008). Further evidence for 
abnormal response preparation comes from electrophysiological studies: Schizophrenia pa-
tients were found to lack higher contingent negative variation when preparing antisaccades 
compared to prosaccades (Klein, Heinks, Andresen, Berg, & Moritz, 2000; Reuter, Herzog, 
Endrass, & Kathmann, 2006) and to present neural abnormalities over prefrontal cortex prior 
to the execution of antisaccades (Kang, Dionisio, & Sponheim, 2011). 
Besides frontal alterations, further relevant differences between schizophrenia and healthy 
controls were found in thalamus (Fukumoto-Motoshita et al., 2009) and striatal regions. Lower 
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brain activation during antisaccades was shown in striatum (Raemaekers et al., 2002) and len-
tiform nucleus (Tu et al., 2006) and volume of the caudate was reported to predict antisaccade 
latency and gain in first episode psychosis (Ettinger, Kumari, Chitnis, et al., 2004). Furthermore, 
Crawford and colleagues (1996) found schizophrenia patients with high error rates to display 
lower regional cerebral blood flow in the anterior cingulate, insula, and striatum than patients 
with normal error rates. 
Another conceivably relevant factor in the explanation of schizophrenia dysfunctions includes 
abnormal timing of hemodynamic responses during antisaccades in schizophrenia. Dyckman 
and colleagues (2011) found delayed and prolonged hemodynamic responses in frontal eye 
fields that did not differ in amplitude during antisaccades for patients compared to healthy 
controls, suggesting that these functions that are necessary to achieve correct antisaccades 
take longer to implement and are more persistent. 
Consistent with intact behavioral performance of prosaccades, no differences in neural activa-
tion were found between patients and healthy controls during basic saccade generation 
(McDowell et al., 2002). Altogether, these findings suggest functionally intact circuit of basic 
saccades, whereas mechanisms underlying the generation of antisaccades display severe dis-
turbances (for an overview see Gooding & Basso, 2008). 
The relationship between antisaccade impairments and severity of schizophrenia symptoms 
revealed mixed findings. In accordance with trait stability independent from clinical status, 
most findings demonstrated no/minimal significant correlations between antisaccade 
measures and schizophrenia symptom severity (Haraldsson et al., 2008; Harris, Reilly, Thase, 
Keshavan, & Sweeney, 2009; Hutton et al., 2004; Kallimani et al., 2009; Nkam et al., 2001; Reilly 
et al., 2014). However, some studies found that poorer antisaccade performance was associ-
ated to higher clinical (predominantly negative) symptom ratings (Ettinger, Kumari, Chitnis, et 
al., 2004; Louchart-De La Chapelle et al., 2005; Müller, Riedel, Eggert, & Straube, 1999; Nieman 
et al., 2000). 
Impairments of antisaccade performance have been found in first-episode/recent-onset (De 
Wilde et al., 2008; Grootens et al., 2008; Hutton, Joyce, Barnes, & Kennard, 2002), medication-
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naïve (Harris et al., 2009), and drug-treated (Hutton et al., 1998; Maruff et al., 1998; Nieman 
et al., 2000) patients as well as in acute (Curtis, Calkins, Grove, Feil, & Iacono, 2001) and remit-
ted (Curtis et al., 2001) schizophrenia. Furthermore, antisaccade deficits have been reported 
in unaffected first-degree relatives of schizophrenia patients (Reilly et al., 2014). Additionally, 
emphasizing their role as core features of the illness (Green, Nuechterlein, et al., 2004), longi-
tudinal studies have reported antisaccade deficits in schizophrenia patients to represent high 
test-retest reliabilities despite fluctuations in clinical states (Calkins et al., 2003; Gooding, 
Mohapatra, & Shea, 2004; Kallimani et al., 2009; Light et al., 2012). Together, these findings of 
time stability independent of clinical symptoms and the presence of deficits in unaffected first-
degree relatives suggest antisaccade impairments to demonstrate a valuable trait biomarker 
of schizophrenia. 
To date, studies that have examined the effects of antipsychotic medication on antisaccades 
in schizophrenia patients have mainly detected no or only few beneficial effects (Burke & 
Reveley, 2002; Harris, Reilly, Keshavan, & Sweeney, 2006; Hill, Reilly, Harris, Khine, & Sweeney, 
2008; Larrison et al., 2011; Müller et al., 1999), possibly due to baseline dependency (Babin et 
al., 2011). 
Conceivable explanations for antisaccade deficits in schizophrenia rather point to cognitive 
than sensory sources (Leonard et al., 2013). Several cognitive functions such as inhibition 
(Barton, Pandita, Thakkar, Goff, & Manoach, 2008), working memory (Hutton et al., 2004), and 
attention (Tendolkar et al., 2005) seem to be involved in the deterioration of antisaccade per-
formance in schizophrenia (for an overview see Gooding & Basso, 2008). Additionally, antisac-
cade deficits can be considered as an essential deficit in goal-directed behavior (Nieuwenhuis 
et al., 2004; Reuter & Kathmann, 2004), a concept that is closely related to symptoms of schiz-
ophrenia (Reuter & Kathmann, 2007; Rinaldi & Lefebvre, 2016). 
In addition to antisaccade deficits in patients with schizophrenia, similar impairments have also 
been found in schizoaffective (Martin et al., 2007; Reilly et al., 2014) and affective disorders 
with psychotic features (Harris et al., 2009; Katsanis, Kortenkamp, Iacono, & Grove, 1997; Reilly 
et al., 2014). Furthermore, borderline personality disorder patients with psychotic features had 
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higher antisaccade error rate that those without these features (Grootens et al., 2008). Under-
lining its specificity to the psychosis spectrum, rather unimpaired (Fukushima et al., 1990; 
Harris et al., 2009) and unstable (Gooding et al., 2004) antisaccade performance was reported 
in affective disorders without psychotic features. Similarly, patients with obsessive compulsive 
disorder demonstrate low or distinct impairments (Damilou et al., 2016; McDowell & 
Clementz, 1997; Spengler et al., 2006) compared to patients from the psychosis spectrum (for 
an overview see Jaafari et al., 2011). 
To summarize, schizophrenia is associated with behavioral antisaccade disturbances, specifi-
cally increased direction errors (Radant et al., 2015) whereas basic saccade generation circuits 
seem to be largely intact (Gooding & Basso, 2008). On the brain functioning level, disruption 
of antisaccades is mainly reflected in abnormal activation of frontal-striatal circuits (Camchong 
et al., 2008; Raemaekers et al., 2002). The antisaccade performance deficits were reported to 
be time-stable and independent from fluctuations in clinical symptoms (Light et al., 2012) and 
current available antipsychotic medication has only minimal beneficial effects (Hill et al., 2008). 
 
iii. Evaluation of SPEM and antisaccades as biomarkers of psychosis 
As discussed above, SPEM and antisaccades meet several important criteria for biomarkers of 
schizophrenia (for a review see Koychev et al., 2011). First, both tasks can be assessed with 
high objectivity, thereby showing high internal consistency and test-retest reliability (Ettinger 
et al., 2003). Furthermore, the tasks are short und their instructions are simple which makes 
them applicable even in severely impaired patients (Klein & Ettinger, 2008). Additionally, in 
contrast to complex and time-consuming neuropsychological assessments, oculomotor 
measures are easy to administer and variables can be analyzed in real time (Benson et al., 
2012). 
Secondly, SPEM and antisaccade measures demonstrate high construct validity. Neural net-
works of SPEM and antisaccades have been well-established in humans (SPEM: Lencer & 
Trillenberg, 2008; antisaccades: McDowell et al., 2008) and non-human primates (SPEM: Ilg & 
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Thier, 2008; antisaccades: Johnston & Everling, 2008). Additionally their cognitive underpin-
nings have been clearly studied and can be manipulated systematically (SPEM: Barnes, 2008; 
antisaccades: Hutton, 2008). 
Third, SPEM and antisaccade impairments have widely been replicated in schizophrenia and 
the psychosis spectrum (SPEM: Lencer et al., 2015; antisaccades: Reilly et al., 2014). In order 
to provide further evidence for using the measures as indicators of pathogenic processes, al-
gorithms to quantify classification accuracies were applied. Using logistic regression ap-
proaches, oculomotor variables (in combination with further biomarkers) were found to be 
useful in the classification of schizophrenia patients with sensitivities between 82%-95% and 
specificities between 83%-88% (Martin et al., 2007; Millard et al., 2016; Price et al., 2006). 
Furthermore, applying neural network algorithms on oculomotor data, patients with schizo-
phrenia can be distinguished from controls with high levels of discrimination (80%-98%; 
Benson et al., 2012; Campana, Duci, Gambini, & Scarone, 1999). 
Fourth, underlining the general responsiveness of SPEM and antisaccade measures to pharma-
cological treatments, both measures were found to display dose-dependent responses to an-
tipsychotic drugs in healthy participants (De Visser et al., 2001; Reilly et al., 2008). Neverthe-
less, the effects of current available antipsychotic drugs on oculomotor performance in pa-
tients with psychosis were found to be of only small benefit or even adverse (Hill et al., 2008; 
Lencer et al., 2008), emphasizing the importance of the development of new compounds. 
Altogether, SPEM and antisaccade measures represent valuable biomarkers that are clearly 
associated to disorders of the psychosis spectrum. In terms of practical application, they might 
be highly beneficial in supporting the diagnosis of cognitive disturbances in psychotic disorders 
(Benson et al., 2012) and in developing alternatives to traditional disorder categories 
(Clementz et al., 2016; Hudgens-Haney et al., 2017; Insel et al., 2010). Furthermore, the as-
sessment of oculomotor control can be helpful in the evaluation of pharmacological responses 
to new therapeutic interventions for schizophrenia patients (Reilly et al., 2008). 
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IV.III Oculomotor biomarkers in the schizotypy and sleep deprivation models 
IV.III.I SPEM, saccades, and schizotypy 
SPEM 
Studies of SPEM in high schizotypes have found performance deficits similar to those reported 
in studies with psychotic patients. An overview of all studies can be found in Table IV—2 and 
an exemplary illustration of SPEM in schizotypy is in Figure IV—2b. Reduced performance in 
schizotypy includes deficits in global measures, e.g., lower quality of SPEM (O’Driscoll, 
Lenzenweger, & Holzman, 1998), higher percentage of poor eyetrackers (Holahan & O’Driscoll, 
2005; Simons & Katkin, 1985), and higher RMSE (Gooding, Miller, & Kwapil, 2000; Smyrnis et 
al., 2007; Van Kampen & Deijen, 2009). Additionally, performance deficits were reported using 
specific SPEM measures, e.g., lower velocity gain (Gooding et al., 2000; Holahan & O’Driscoll, 
2005; Kattoulas, Evdokimidis, et al., 2011; Koychev et al., 2016), and higher frequency of sac-
cade rate (Lenzenweger & O’Driscoll, 2006; Smyrnis et al., 2007). In most studies, different 
saccade types were combined to compute the total rate of saccades (Koychev et al., 2016; 
Schmechtig et al., 2013; Smyrnis et al., 2007). The few studies that have distinguished saccade 
subtypes, discovered positive associations between schizotypy and catch-up (Lenzenweger & 
O’Driscoll, 2006) but not anticipatory (Gooding et al., 2000) saccade rate. 
Poor SPEM have been found in high schizotypes comprising the positive, negative, and disor-
ganized factors (Gooding et al., 2000; Holahan & O’Driscoll, 2005; Kattoulas, Evdokimidis, et 
al., 2011; Lenzenweger & O’Driscoll, 2006; Smyrnis et al., 2007), and the total schizotypy score 
(Koychev et al., 2016; Schmechtig et al., 2013; Van Kampen & Deijen, 2009). 
Additionally, schizotypy-related SPEM deficits were found using different methodological ap-
proaches. Most studies have examined extreme groups with high schizotypes and average 
(Gooding et al., 2000; Holahan & O’Driscoll, 2005; Kattoulas, Smyrnis, et al., 2011; Koychev et 
al., 2016; Smyrnis et al., 2007; Van Kampen & Deijen, 2009) and/or low (Koychev et al., 2016; 
Simons & Katkin, 1985) control participants. Additionally, few studies have investigated schizo-
typal traits in participants with high or poor oculomotor accuracy (Kendler et al., 1991; Siever, 
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1982; Siever et al., 1989). Furthermore, correlative designs have been used to explore associ-
ations between schizotypy and SPEM (Kattoulas, Smyrnis, et al., 2011; Kelley & Bakan, 1999; 
Lenzenweger & O’Driscoll, 2006; Smyrnis et al., 2007). 
However, there are also studies that have not detected any schizotypy-related differences in 
SPEM (Blackwood et al., 1994; Schmechtig et al., 2013; Thaker, Cassady, Adami, Moran, & Ross, 
1996). Reasons for the non-significant findings may include too unspecific and imprecise SPEM 
measures (Blackwood et al., 1994; Thaker et al., 1996) and extremely strict study inclusion 
criteria that may have blurred the rather small effects of schizotypy (Schmechtig et al., 2013). 
Almost all studies have focused on closed-loop maintenance SPEM. In most of these studies, 
sinusoidal movement patterns using frequencies ranging from 0.2Hz to 0.8Hz were applied 
(Holahan & O’Driscoll, 2005; Kelley & Bakan, 1999; Koychev et al., 2016; Lenzenweger & 
O’Driscoll, 2006). Additionally, some studies have employed triangular movement patterns 
with velocities ranging from 8°-30°/sec (O’Driscoll et al., 1998; Smyrnis et al., 2007; Van 
Kampen & Deijen, 2009). Similar to schizophrenia patients (O’Driscoll & Callahan, 2008), per-
formance deficits in schizotypy were found to be largely independent from frequency/velocity 
(Koychev et al., 2016; Smyrnis et al., 2007; Van Kampen & Deijen, 2009) occurring with differ-
ent target movement patterns (Koychev et al., 2016; Van Kampen & Deijen, 2009). Until now, 
there is only one study that has investigated predictive SPEM in schizotypy. Kattoulas and col-
leagues (2011) found disorganized schizotypy to be related to lower residual gain and, unex-
pectedly, high negative schizotypes had higher residual gain. These results remain inconclusive 
and need to be further investigated. Until now, there is no research on the open-loop response 
in high schizotypal subjects. 
A further major issue comprises the neural correlates of SPEM deficits in schizotypy. To date 
there is no study that has addressed the underlying neural mechanisms of reduced SPEM per-
formance found in high schizotypes. 
In summary, schizotypal traits are associated with lower maintenance SPEM, e.g., higher RMSE 
and lower velocity gain (Gooding et al., 2000; Koychev et al., 2016), compatible with findings 
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from schizophrenia patients (O’Driscoll & Callahan, 2008). However, the neural mechanisms of 
these behavioral performance deficits remain unclear. 
 
Prosaccades and antisaccades 
Previous research in high schizotypes have reported antisaccade deficits that are similar to 
those observed in patients with psychotic disorders. An overview of these studies is in Table 
IV—3. Most importantly, high schizotypes have been found to demonstrate higher rates of 
direction errors (Aichert, Williams, Möller, Kumari, & Ettinger, 2012; Ettinger et al., 2005; 
Gooding, Shea, & Matts, 2005; Holahan & O’Driscoll, 2005; Koychev et al., 2016; Schmechtig 
et al., 2013). Additionally, most studies have applied prosaccade tasks as a control condition. 
In accordance with psychotic patients (Broerse et al., 2001; Gooding & Basso, 2008), schizo-
types were reported to show intact prosaccade performance (Aichert et al., 2012; Gooding, 
1999; Gooding, Shea, et al., 2005; Larrison, Ferrante, Briand, & Sereno, 2000). Contrary to 
schizophrenia (Gooding & Basso, 2008), schizotypy is not associated to prolonged antisaccade 
latencies (Aichert et al., 2012; Ettinger et al., 2005; Gooding, Shea, et al., 2005; Holahan & 
O’Driscoll, 2005; Koychev et al., 2016). 
Increased antisaccade direction errors have been found to be associated with positive (Aichert 
et al., 2012; Ettinger et al., 2005, 2017; Gooding, Shea, et al., 2005; Larrison et al., 2000), neg-
ative (Gooding, 1999; Gooding, Shea, et al., 2005), as well as to overall high schizotypy 
(Koychev et al., 2016; Schmechtig et al., 2013). However, in studies that have compared posi-
tive and negative schizotypy, antisaccade deficits were found to arise more consistently in pos-
itive schizotypes (Ettinger et al., 2005, 2017; Holahan & O’Driscoll, 2005). 
Furthermore, schizotypy-related antisaccade deficits have been discovered with different 
methodological approaches. Most studies used extreme groups using mean deviation criteria 
with high schizotypes and average (Gooding et al., 2000; Gooding, Shea, et al., 2005; Koychev 
et al., 2016; Larrison et al., 2000; Schmechtig et al., 2013) and/or low (Koychev et al., 2016; 
Larrison et al., 2000) control subjects. Additionally, a study of Klein and colleagues (2000) ap-
plied a median split to discriminate high and low schizotypy groups. Furthermore, three studies 
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have investigated larger samples with correlative analyses (Aichert et al., 2012; Ettinger et al., 
2005; Smyrnis et al., 2003). 
However, there are also studies that revealed no differences in antisaccade performance for 
high and low schizotypes (Klein et al., 2000; Thaker et al., 2000, 1996). Reasons for the lack of 
differences may include methodological details. For example, the gap and overlap task varia-
tions were used in the study by Klein and colleagues (2000), but not the standard step task. 
Studies that discovered elevated antisaccade direction error rate in schizotypy have mostly 
applied a step task design (Aichert et al., 2012; Ettinger et al., 2005; Gooding, Shea, et al., 2005; 
Koychev et al., 2016; Schmechtig et al., 2013). Additionally, Holahan and O’Driscoll (2005) com-
pared step, gap, and overlap designs in one study and schizotypy-related group differences 
were only detected using the step design. However, a study by Larrison and colleagues (2000) 
also reported effects of schizotypy in a gap design antisaccade task. Further reasons for non-
significant results may be due to imprecise definitions of schizotypal traits. Despite considera-
ble overlap between schizophrenia spectrum personality symptoms and schizotypy measured 
with the Chapman Scales (Thaker, Moran, Adami, & Cassady, 1993), Thaker and colleagues 
(2000, 1996) did not detect any performance differences between healthy subjects with and 
without schizophrenia spectrum symptoms. 
Until today, there is only one study that has examined the neural mechanisms of antisaccade 
performance in schizotypy. Aichert and colleagues (2012) demonstrated that higher positive 
schizotypy was associated to less brain activity in putamen, cerebellum, thalamus, and visual 
cortex during antisaccades compared to fixation, a pattern that overlaps with dysfunctions 
previously reported in schizophrenia patients (Camchong et al., 2008; Fukumoto-Motoshita et 
al., 2009; Raemaekers et al., 2002).To summarize, high schizotypes have been found to display 
elevated antisaccade direction errors, similar to patients with psychotic disorders (Koychev et 
al., 2016; Reilly et al., 2014). In addition, the neural correlates of poor antisaccade performance 
were found to overlap between schizotypy (Aichert et al., 2012) and schizophrenia 
(Raemaekers et al., 2002) which underlines the meaningfulness and utility of schizotypy as a 
model system for schizophrenia. 
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sinusoidal, 0.4Hz Poor eyetrackers had higher social introversion. 
Simons & Katkin 
(1985) 
extreme groups [(a) n=17 PhysAn, 
n=16 low controls; (b) n=37 
PhysAn/PerAb, n=14 average con-
trols] 
Chapman Scales [positive, 
negative] 
sinusoidal, 0.33Hz/0.4Hz 
[pursuit quality, % poor eye-
trackers] 
There were no differences for pursuit quality. 
High schizotypes had higher % poor eyetrackers. 
Siever et al. (1989) n=31 good eyetrackers, n=13 poor 
eyetrackers 
Rating Scale for Borderline 
and Schizotypal Characteris-
tics [positive, negative] 
sinusoidal, 0.4Hz Poor eyetrackers scored higher on various schizo-
typy characteristics. Additionally, SPEM accuracy 
was negatively correlated to social isolation. 
Kendler et al. (1991) n=52 good eyetrackers, n=5 poor 
eyetrackers [twin study] 
Structured Interview for 
Schizotypy, SRQ [positive, 
negative] 
sinusoidal, 0.3Hz [RMSE] There were no differences in schizotypy traits 
and positive symptom schizotypy between the 
good and poor eyetrackers. Poor eyetrackers had 
higher negative symptom schizotypy. 
Blackwood et al. 
(1994) 
extreme groups [n=17 high, n=17 
controls] 
Baron Schedule for Schizoty-
pal Personality Disorder 
sinusoidal, 0.4Hz [ln (S/N)] There were no differences between high and low 
schizotypes. 
Thaker, Cassady, 
Adami, Moran, & Ross, 
(1996) 
n=46 without symptoms, n=22 with 
symptoms 
Schizophrenia spectrum 
symptoms [highly correlated 
to the Chapman Scales; 
Thaker et al., 1993] 
sinusoidal, 0.5Hz [pursuit 
quality] 
There were group differences on SPEM perfor-





extreme groups [n=31 PerAb, n=24 
average controls] 
Chapman Scales [positive] triangular, 8°/sec [pursuit 
quality] 
High schizotypes had lower quality of pursuit. 
Kelley & Bakan (1999) correlations [n=121] MMPI [total] sinusoidal, 0.4Hz/0.8Hz 
[RMSE] 
Higher schizotypy was associated to higher 
RMSE.  
Gooding et al. (2000) extreme groups [n=97 PerMag, 
n=54 SocAn, n=31 PhysAn, n=94 
controls] 
Chapman Scales [positive, 
negative] 
sinusoidal, 0.4Hz [RMSE, 
gain, total and anticipatory 
saccades] 
High schizotypy groups had higher RMSE and 
lower gain. No differences were found for total 
and anticipatory saccades. 
     
INTRODUCTION [45] 
     
Holahan & O’Driscoll 
(2005) 
extreme groups [n=21 PerAb, n=20 
PhysAn, n=29 controls] 
Chapman Scales [positive, 
negative] 
sinusoidal, 0.4Hz [% poor 
eyetrackers, gain] 
Both groups had higher % poor eyetrackers and 




correlations [n=300] SPQ [total, positive, negative, 
disorganized] 
sinusoidal, 0.4Hz [gain, CUS] SPQ total score and all sub-scales were associ-
ated with lower gain and higher disorganization 
was correlated with higher CUS. 
Smyrnis et al. (2007) correlations [n=1087] and extreme 
groups [n=55 PerAb, n=26 SPQ to-
tal, n=34 cognitive-perceptual, n=41 
negative, n=23 disorganization, 
n=19 paranoia, n=1032-1068 con-
trols] 




[RMSE, gain, total saccade 
frequency] 
Negative schizotypy was positively correlated to 
saccade frequency at 30°/sec. No other associa-
tions were found in the whole sample. Using sub-
groups with extreme scores, high PerAb had 
higher RMSE and high disorganized presented 
lower gain and higher saccade frequency. 
Van Kampen & Deijen 
(2009) 
extreme groups [n=19 high, n=19 
average controls] 
SSQ [total] triangular, 5°,10°,20°/sec 
[RMSE] 
High schizotypes showed higher RMSE than con-
trols. 
Kattoulas et al. (2011) correlations [n=762-763] and ex-
treme groups [n=46 PerAb, n=19 
SPQ total, n=34 cognitive-percep-
tual, n=32 negative, n=17 disorgani-
zation, n=15 paranoia, n=717-747 
controls] 
Chapman Scales, SPQ [total, 
positive, negative, disor-
ganized] 
triangular with blanking, 
10°/sec [gain, latency, decel-
eration time] 
Disorganized schizotypy was negatively related to 
residual gain. Using sub-groups with extreme 
scores, high negative schizotypes presented 
higher residual gain. No effects were found for 
latency and deceleration time. 
Schmechtig et al. 
(2013) 
extreme groups separated by three 
drugs and placebo 
SPQ [total] sinusoidal, 
0.25Hz/0.5Hz/0.75Hz [gain, 
total saccade frequency] 
No effects for schizotypy were found. 
Koychev et al. (2016) extreme groups [n=30 high, n=31 
average, n=22 low] 
SPQ [total] sinusoidal, 
0.25Hz/0.5Hz/0.75Hz [gain, 
total saccade frequency] 
Average schizotypes displayed lower gain com-
pared to low schizotypes. High schizotypes per-
formed intermediate and there were no differ-
ences to the low and average schizotypy groups. 
No differences were found for frequency of sac-
cades. 
Notes. Studies are presented in chronological order. Only studies using adult samples are included. SPEM=smooth pursuit eye movements. SRQ=self-report questionnaire for schizotypy. 
PhysAn=physical anhedonia scale. SocAn=social anhedonia scale. PerAb=perceptual aberration scale. PerMag=perceptual aberration/magical ideation scale. MMPI=Minnesota multiphasic 
personality inventory. SPQ=schizotypal personality questionnaire. SSQ=schizotypic syndrome questionnaire. RMSE=root mean square error. CUS=catch-up saccade.  
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Thaker et al. (1996) n=45 without symptoms, n=23 with 
symptoms 
Schizophrenia spectrum 
symptoms [highly correlated 
to the Chapman Scales; 
Thaker et al., 1993] 
PS, AS [step]  There were no group differences on PS and AS 
performance. Saccade performance was not as-




extreme groups [n=31 high, n=24 
average controls] 
Chapman Scales [positive] AS [step, 12°] [% correct, la-
tency, perseverative errors, 
non-perseverative errors] 
High schizotypes had lower % correct AS and a 
higher rate of perseverative errors. The groups 
did not differ in latencies to correct antisaccades 
or errors and non-perseverative errors. 
Gooding (1999) extreme groups [n=90 PerMag, 
n=39 SocAnh, n=89 controls] 
Chapman Scales [positive, 
negative] 
PS, AS [step, 4°, 8°, 12°] 
[direction errors, latency] 
Both high schizotypy groups had higher AS error 
rate than controls. No group differences were 
found for PS error rates and PS and AS latencies. 
Klein, Brügner, 
Foerster, Müller, & 
Schweickhardt (2000) 
extreme groups using median split 
[n=20 high, n=21 average controls] 
SPQ [total] PS, AS [gap, overlap, 4°] 
[direction errors, latency, % 
anticipatory saccades, % ex-
press saccades] 
There were no differences between the two 
groups. 
Larrison, Ferrante, 
Briand, & Sereno, 
(2000) 
extreme groups [n=16 high, n=7 av-
erage, n=13 low] 
RISC [positive] PS, AS [gap, non-gap, 7.2°] 
[direction errors, latency] 
High schizotypes had higher error rate in the AS 
gap condition compared to low schizotypes. No 
other effects were significant. 
Thaker et al. (2000) n=37 without symptoms, n=25 with 
symptoms 
Schizophrenia spectrum 
symptoms [highly correlated 
to the Chapman Scales; 
Thaker et al., 1993] 
PS, AS [step, 10°-150°] 
[direction errors, latency, 
gain, peak velocity] 
There were no group differences and associa-
tions between saccade measures and spectrum 
symptoms. 
Smyrnis et al. (2003) correlations [n=1273] and extreme 
groups [n=68 PerAb, n=39 SPQ, 
n=1205-1234 controls] 
Chapman Scales, SPQ [posi-
tive, total] 
AS [step, 2-10°] [direction er-
rors, mean and SDs of la-
tency] 
Schizotypy was only weakly associated to AS per-
formance. High PerAb group had higher direction 
error rate and SD of AS latency than controls. No 




     
Ettinger et al. (2005) correlations [N=115] RISC, PSQ-80 [positive, nega-
tive, thought disorder] 
PS, AS [step, 6°, 12°] [direc-
tion errors, latency, spatial 
error] 
AS direction errors and PS spatial error were pos-
itively associated with positive schizotypy. Addi-
tionally, PS latency was negatively correlated to a 
measure of thought disorder. 
Gooding, Shea, & 
Matts (2005) 
extreme groups [n=50 PerMag, 
n=32 SocAnh, n=39 controls] 
Chapman Scales [positive, 
negative] 
PS, AS [step, 4°, 8°, 12°] [di-
rection errors, latency] 
Both high schizotypy groups had higher AS direc-
tion errors than controls and, additionally, at fol-
low-up, the SocAnh group produced more error 
than the PerMag group. No group differences 
were found for PS and AS latencies. 
Holahan & O’Driscoll 
(2005) 
extreme groups [n=21 PerAb, n=20 
PhysAn, n=29 controls] 
Chapman Scales [positive, 
negative] 
AS [step, gap, overlap, 10°] 
[direction errors, latency] 
The PerAb group showed higher AS direction er-
ror rates in the step task compared to controls 
and the PhysAnh group were found to score in-
termediate. No group differences were found for 
latencies and the gap and overlap tasks. 
Aichert, Williams, 
Möller, Kumari, & 
Ettinger (2012) 
correlations [N=54] RISC [positive] PS, AS [step, 8°] [direction er-
rors, latency] 
AS error rate was related to higher schizotypy. 
No associations were found for latencies. Fur-
thermore, higher schizotypy was associated to 
less activation in putamen, cerebellum, thala-
mus, and visual cortex during AS and less activity 
in posterior IPS, SEF, and visual cortex during PS. 
Schmechtig et al. 
(2013) 
extreme groups separated by three 
drugs and placebo 
SPQ [total] PS, AS [step, 7.25°, 14.5°] [di-
rection errors, latency, ampli-
tude gain, peak velocity] 
High schizotypes made more direction errors 
than medium schizotypes in the placebo condi-
tion. No effects for schizotypy were found for the 
other variables. 
Koychev et al. (2016) extreme groups [n=30 high, n=31 
average, n=22 low] 
SPQ [total] AS [step, 7.25°, 14.5°] [direc-
tion errors, latency, saccade 
amplitude, peak velocity] 
High schizotypes had higher direction error rates 
than low schizotypy controls. No effects were 
found for the other variables. 
Notes. Studies are presented in chronological order. Only studies using adult samples are included. PS=prosaccades. AS=antisaccades PhysAn=physical anhedonia scale. SocAn=social 
anhedonia scale. PerAb=perceptual aberration scale. PerMag=perceptual aberration/magical ideation scale. SPQ=schizotypal personality questionnaire. RISC=Rust inventory of schizotypal 
cognitions. PSQ-80=personality syndrome questionnaire. For further overviews, see also Myles, Rossell, Phillipou, Thomas, & Gurvich (2017) and Wan, Thomas, Pisipati, Jarvis, & Boutros 
(2017). 
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IV.III.II SPEM, saccades, and sleep deprivation 
SPEM 
Healthy subjects have been found to show sleep deprivation-related impairments on SPEM 
performance that are similar to those seen in patients with psychotic disorders. An overview 
of all studies can be found in Table IV—4 and an exemplary illustration of SPEM after sleep 
deprivation is in Figure IV—2d. The performance deficits mainly comprised reduced mainte-
nance gain (De Gennaro, Ferrara, Urbani, & Bertini, 2000; Fransson et al., 2008; Tong, Maruta, 
Heaton, Maule, & Ghajar, 2014). Additionally, there are findings of reduced accuracy (Fransson 
et al., 2008) and elevated anticipatory but not catch-up saccade rate (Tong et al., 2014). 
Durations of sleep deprivation ranged from 7 hours (Porcu, Ferrara, Urbani, Bellatreccia, & 
Casagrande, 1998) to 40 hours (De Gennaro et al., 2000). All studies examined closed-loop 
SPEM and most of them used sinusoidal tasks (De Gennaro et al., 2000; Tong et al., 2014) with 
frequencies between 0.2Hz-1.1Hz. Additionally, there is one study that has applied stimuli 
moving with different constant velocities (10°-40°/sec; Fransson et al., 2008). Until now, there 
is no study that has investigated the effects of sleep deprivation in open-loop and predictive 
SPEM tasks. 
Furthermore, there are also studies that did not find any sleep deprivation-related differences 
in the performance of SPEM (Quigley, Green, Morgan, Idzikowski, & King, 2000; Van Steveninck 
et al., 1999). Both studies compared the performance of subjects after a normal sleep night 
and a night of sleep deprivation, a design that has been successfully applied in other studies 
(Fransson et al., 2008; Tong et al., 2014). However, both studies failed to provide information 
on their measures and, additionally, Quigley and colleagues (2000) did not describe the param-
eters of the task. Therefore, it is difficult to guess any reasons for the non-significant results. 
In summary, there is evidence for sleep deprivation to deteriorate the maintenance of SPEM 
(Fransson et al., 2008; Tong et al., 2014) in a similar way to disturbances that are present in 
schizophrenia patients (O’Driscoll & Callahan, 2008). However, further studies are needed to 
characterize these deficits in more detail using additional measures and task variations. 
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Prosaccades and antisaccades 
Consistent with increased antisaccade error rates and latencies in psychosis, sleep deprivation 
was found to disrupt antisaccade performance in healthy subjects (see Table IV—5 for an over-
view). Total sleep deprivation was reported to increase antisaccade direction errors and laten-
cies (Bocca, Marie, & Chavoix, 2014). Additionally, a recent study displayed higher antisaccade 
error rates even after partial sleep deprivation (Lee, Manousakis, Fielding, & Anderson, 2015). 
However, other studies failed to find sleep deprivation-related increases in antisaccade impair-
ments (Crevits, Simons, & Wildenbeest, 2003; Gais et al., 2008; Zils, Sprenger, Heide, Born, & 
Gais, 2005). As time-of-day was found to impact on response control (Manly, Lewis, Robertson, 
Watson, & Datta, 2002; Wachowicz et al., 2015), reasons for the inconsistent findings may 
include confounding with circadian effects (Crevits et al., 2003; Fimm & Blankenheim, 2016). 
In contrast to largely intact prosaccade performance in schizophrenia (Gooding & Basso, 2008), 
sleep deprivation was additionally found to impair prosaccade performance, e.g., increase di-
rection errors (Porcu et al., 1998) and latencies (Bocca & Denise, 2006; De Gennaro et al., 2000; 
Van Steveninck et al., 1999) and reduce spatial accuracy (Bocca & Denise, 2006; Porcu et al., 
1998; Zils et al., 2005). 
Sleep deprivation in these experimental settings was carried out once, with durations varying 
between 7 hours (Porcu et al., 1998) and 72 hours (Thomas et al., 2003). Additionally there are 
studies that have examined the effects of chronic sleep deprivation and of wakefulness due to 
working conditions. Persistent partial sleep deprivation with seven days of only 3 to 5 hours 
sleep per night was shown to prolong saccadic peak velocities (Russo et al., 2003; however see: 
Wachowicz et al., 2015). Another study compared the saccade performance of physicians dur-
ing a 24 hours on-call shift to a routine working day (non on call). They found that the on-call 
shift yielded in increased time awake and longer latencies of saccades (lower rates of saccades 
with latencies below 150ms; Ernst et al., 2014). 
Overall, prolonged wakefulness adversely affects the performance of both antisaccades and 
prosaccades. The disturbances of antisaccade control (Bocca et al., 2014; Lee et al., 2015) cor-
respond to findings of patients with psychotic disorders (Radant et al., 2015). Until now, there 
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are only few studies that have explicitly compared antisaccades and prosaccades within one 
study (Crevits et al., 2003; Gais et al., 2008; Lee et al., 2015; Zils et al., 2005) and only one of 
these studies did not compare morning and evening data (Lee et al., 2015). Thus, further stud-
ies are needed to allow direct comparisons of sleep deprivation effects on these tasks. 
 



















Porcu et al. 
(1998) 
N=5 males sinusoidal move-
ment pattern with 6 
frequencies be-
tween 0.2-0.7Hz 
velocity gain, phase 
shift 
up to 7h Measurements were conducted at 
12pm, after NSC, and later at midnight, 
2am, 4am, and 6 am with intermediate 
day sleep [2:30pm-11:00pm]. 
For velocity gain the performance 
decreased at the end of the night. 
There were no effects of SD for 
phase shift.  
van 
Steveninck 





ment pattern with 9 
frequencies be-
tween 0.3-1.1Hz 
not specified 1 night Measurements were conducted after 
NSC, during SD, and after SD. Order of 
NSC and SD was randomized [within-
subjects] and nights were scheduled 1 
week apart. 
There were no significant effects of 
SD on SPEM variables. 
De Gennaro 
et al. (2000); 
Ferrara et al. 
(2000) 
N=9 males sinusoidal move-
ment pattern with 6 
frequencies be-
tween 0.2-0.7Hz 
velocity gain, phase 
shift 
up to 40h Measurements were taken every 2h 
from 10am in the pre-deprivation day to 
10pm of the day following SD. 
Velocity gain was reduced on meas-
urements after SD compared to 
NSC. There were no effects of SD 
for phase shift. 





not specified not specified 1 night Measurements were taken before/after 
NSC/SD on two consecutive test days on 
the same time of day [between-sub-
jects]. 











24h, 36h Participants were measured after NSC 
and after 24h and 36h of SD. Order of 
NSC and SD was randomized [within-
subjects] and nights were scheduled 1 
week apart. 
Velocity gain was reduced after 36h 
of SD and accuracy was lower after 
24h SD but recovered at 36h of SD. 









gential error, gain, 




up to 26h Measurements were taken at 6:30am 
after NSC and at 2:00am and 6:30am af-
ter SD.  
SD reduced velocity gain and aver-
age power of tangential velocity and 
increased standard deviations and 
anticipatory saccade rate. No ef-
fects were found for phase error, 
radial error, average power of radial 
velocity, and catch-up saccades. 
Notes: NSC=normal sleep control night. SD=sleep deprivation. Unless otherwise indicated, studies included healthy participants. Studies are presented in chronological order. Table is 
adapted from Meyhöfer and colleagues (2016).  
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Porcu et al. 
(1998) 
N=5 males PS [5-30°] latency, 
gain, error 
rate 
up to 7h Measurements were conducted at 12pm af-
ter NSC and later at midnight, 2am, 4am, 
and 6am with intermediate day sleep 
[2:30pm-11:00pm].  
For gain and error rate the per-
formance decreased at the end of 
the night. There were no SD ef-




N=9, age [n=5 fe-
males, n=4 males] 
PS [15°, 20°] latency, 
peak veloc-
ity 
1 night Measurements were conducted after NCS, 
during SD, and after SD. Order of NSC and 
SD was randomized [within-subjects] and 
nights were scheduled 1 week apart. 
After SD there was a decrease in 
peak velocity and an increase in 
saccadic latency. 
De Gennaro 
et al. (2000); 
Ferrara et al. 
(2000) 
N=9 males PS [5-30°] latency, 
gain, peak 
velocity 
up to 40h Measurements were taken every 2h from 
10am in the pre-deprivation day to 10pm of 
the day following the SD. 
Performance for latency and peak 
velocity was worsened on meas-
urements after the day following 
SD. No SD effects for gain were 
found. 
Quigley et al. 
(2000) 
N=16 [n=8 females, 
n=8 males] 
not specified e.g. peak 
velocity, ac-
celeration 
1 night Measurements were taken before/after 
NSC/SD on two consecutive test days on the 
same time of day [between-subjects]. 
Peak velocity and acceleration 
were significantly decreased after 
SD. 
Crevits et al. 
(2003) 
N=21 [n=11 females, 
n=10 males] 
block design, fixed 
order: PS [14°], 
voluntary sac-




20h Measurements were conducted on the 
evening before SD [9:30pm] and on the 
morning after SD [6am]. 
There were no significant differ-
ences between the measure-
ments. 
Thomas et al. 
(2000;2003) 
N=17 males PS [20°] saccadic ve-
locity 
24h, 48h, 72h Measurements were conducted on baseline 
and after the next consecutive days of SD. 
There was a decrease in saccadic 
velocity with prolonged SD. 
Rowland et al. 
(2005) 
N=12 [n=6 females, 
n=6 males] 
PS [20°] peak veloc-
ity 
64h Measurements were conducted at baseline 
[every 3 h], after partial sleep deprivation 
[every 3h], and after total sleep deprivation 
[every 3h]. 
Saccadic peak velocity decreased 
with duration of total SD. 
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Zils et al. 
(2005) 
N=15 males block design: PS 
[gap, 10° and 20°], 
AS [gap, 10° and 







24.5h Measurements were conducted in the even-
ing before the NSC/SD night [8pm], in the 
morning [7:30am] after NSC/SD, and in the 
morning after a recovery night [7:30am]. Or-
der of NSC and SD was randomized [within-
subjects] and nights were scheduled at least 
4 weeks apart. 
PS: Gain and peak velocity were 
reduced after SD. No SD effect for 
latency. AS: Peak velocity was re-
duced after SD. No SD effects for 
latency, gain, and error rate. 
MGS: There were longer latencies 
and reduced peak velocity after 




N=10 males block design: PS 





1 night Measurements were conducted in the 
morning [10:00am] after NSC and after a 
night of SD. Order of NSC and SD was ran-
domized [within-subjects] and nights were 
scheduled 2 weeks apart. 
Latency was increased after SD 
especially for the gap task and 
gain after SD was reduced for 
both tasks. There were no SD ef-
fects for peak velocity. 
Fransson et 
al. (2008) 
N=18 [n=8 females, 
n=10 males] 





24h, 36h Participants were measured after NSC and 
after 24h and 36h of SD. Order of NSC and 
SD was randomized [within-subjects] and 
nights were scheduled 1 weeks apart. 
Peak velocity decreased after SD 
[24h and 36h], gain was higher af-
ter 36h of SD, and the ratio be-
tween saccade velocity and am-
plitude was reduced after SD 
[24h and 36h]. 
Gais et al. 
(2008) 
N=20 [n=10 females, 
n=10 males] 
block design: PS 







1 night Measurements were taken in the evening 
before the NSC/SD night [8pm], in the morn-
ing after NSC/SD [7:30am], and in the fol-
lowing morning after a night of recovery 
sleep [7:30am]. Subjects were randomly as-
signed to one of the groups [between-sub-
jects]. 
PS and AS latencies were reduced 
only after sleep [for the NSC 
group after the first sleep night, 
for the SD group after the recov-
ery night] and peak velocity was 
decreased after SD. There were 
no SD effects for gain and error 
rate. 
Goldich et al. 
(2010) 
N=13 [n=8 females, 
n=5 males] 
PS [26.8°] saccade ve-
locity 
up to 28h Measurements were taken every hour after 
two nights of sleep [8am-1pm], the day be-
fore SD [8am, 10am, 12am], and the night 
during SD [11pm, 1am, 3am, 5am, 8am, 
10am, 12am]. 
Saccade velocity was decreased 
during SD [for measurements at 
8am-12am]. 
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Grace et al. 
(2010) 
N=10 healthy partic-
ipants [n=2 females, 
n=8 males] 
PS [35°] peak veloc-
ity 
1 night Healthy participants either received intrave-
nous morphine or saline placebo infusion, 
both before and after SD. Measurements 
were taken pre- and post-dose [two-way 
crossover, randomized, double-blind, pla-
cebo-controlled]. 
Peak velocity was decreased both 
after SD and morphine infusion 
and there was an additive effect 
of SD and morphine infusion. 
Hirvonen et 
al. (2010) 
N =11 males block design: PS 




up to 60h Measurements were taken every six hours 
during SD. 






males, n=8 males]; 
N=26 sleep- de-
prived [n=12 fe-
males, n=14 males] 
PS saccadic ve-
locity 
up to 26h Non sleep-deprived subjects had two meas-
urements before and three measurements 
after NSC [between 8am-8pm]. Participants 
in the SD condition completed five testing 
sessions between 8pm and 10am during the 
SD. 
Peak velocity remained stable in 
the NSC but decreased in the SD 
condition. 
Bocca et al. 
(2014) 
N=12 [n=4 females, 
n=8 males] 
AS [gap, 15°] latency, ICV 
latency, er-
ror rate 
30h Participants were measured after NSC [2pm] 
and after 30h of SD [2pm]. Order of NSC and 
SD was randomized [within-subjects] and 
nights were scheduled 2 weeks apart. 
SD increased AS mean latency, 
ICV of latency, and error rate.  
Lee et al. 
(2015) 
N=16 males block design, or-
der was counter-
balanced: PS 
[step, 5°, 10°], AS 





stricted to 5h 
[2am-7am]. 
Participants either received a drink with or 
without alcohol. Measurements were taken 
after NSC and sleep restriction [1pm] [4 con-
ditions, within-subjects]. Conditions took 
place at least 5 days apart. 
PS: After sleep restriction alone, 
there was a reduction of saccadic 
latency. AS: There was an in-
crease in saccadic latency for the 
combined alcohol and sleep re-
striction condition. Error rate was 





N=13 males block design, fixed 
order: PS [gap, 6°, 
12°; gap/overlap, 





up to 24h Measurements were taken every four hours 
during the SD. 
There were no significant effects 
of SD. 
Notes: NSC=normal sleep control night. SD=sleep deprivation. PS=prosaccades. AS=antisaccades. MGS=memory-guided saccades. ICV= intra-individual coefficient of variation. Unless 
otherwise indicated, studies included healthy participants. Studies are presented in chronological order. Table is adapted from Meyhöfer and colleagues (2016). 
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IV.IV Open questions and goals of the current thesis 
Current antipsychotic drugs have little beneficial effects on cognitive disturbances in patients 
with psychotic disorders (Nielsen et al., 2015). However, as cognitive impairments have widely 
been emphasized as a core feature of schizophrenia (Green, Nuechterlein, et al., 2004), new 
treatments are urgently needed (Reilly & Sweeney, 2014). 
Model systems of psychosis are one approach in further investigating the pathophysiology of 
psychosis and aiding the development of new treatments (Carpenter & Koenig, 2008), espe-
cially when combined with well-studied and symptom-related biomarkers. Due to short and 
specific tasks, oculomotor biomarkers are particularly suitable to aid further investigation on 
model systems and drug development (Klein & Ettinger, 2008). 
Antisaccades have been found to represent well-validated trait biomarkers of psychosis (Reilly 
et al., 2014). Due to repeated measurements, high time stability is required to apply antisac-
cades as biomarkers in clinical trials (Nuechterlein et al., 2008). However, a detailed description 
of situational (state) and time-stable (trait) aspects in the antisaccade tasks in standard labor-
atory settings is missing (study 1). 
Based on previous research, schizotypy constitutes a useful model systems of psychotic disor-
ders (Barrantes-Vidal et al., 2015; Kwapil & Barrantes-Vidal, 2015), especially when combined 
with oculomotor biomarkers. However, until now, there is no research on the underlying neu-
ral mechanisms of SPEM in schizotypy (study 2). 
Furthermore, sleep deprivation has been proposed as a model system of psychosis in rats (Frau 
et al., 2008). Further research to validate the model system in humans is needed (study 3). 
Additionally, the combination of a trait (schizotypy) and a state (sleep deprivation) model might 
be especially valuable in modelling psychotic symptoms (study 4). 
To investigate the outlined goals, the work reported in this dissertation combined recording of 
eye movement data, latent-state-trait (LST) modeling, and functional magnetic resonance im-
aging (fMRI).  
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V METHODS 
The following chapter includes a brief description of the methods applied in the current dis-
sertation. The first part introduces the recording and analysis of oculomotor data. In the sec-
ond part is a short outline of LST theory and the models that can be used to compute the 
amount of trait and state variation in a given measure. The third part deals with the basic as-
sumptions of fMRI as a powerful tool to study the neural mechanisms of cognitive processes. 
V.I Recording and analysis of eye movements 
“The eyes have it!” 
[Gegenfurtner, 1999] 
 
A number of methods are available to record changes in eye and/or gaze position. Commonly 
used eye movement measurement methodologies comprise the electro-oculography, scleral 
contact lens/search coil, video-oculography, and video-based combined pupil and corneal re-
flection (VCPCR) techniques (for extensive overviews refer to Duchowski, 2007; Young & 
Sheena, 1975). The VCPCR method is the most frequently applied approach and provides an 
opportunity to measure the point of regard (eye position with relation to its orientation in the 
space). To be able to separate eye movements from head rotation, two reference points on 
the eye, namely pupil center and corneal reflection from an infra-red light source, are recorded 
and brought into relation. Thus, the method is based on the observation that eye movements 
lead to rotation of the pupil whereas the corneal reflection (typically the first Purkinje image) 
remains relatively stable (Duchowski, 2007). 
The calculation of the gaze position can be divided into subsequent steps of image acquisition, 
image analysis, and gaze estimation (Holmqvist et al., 2011). First, images of the eye are rec-
orded by the camera, with the number of images depending on the sampling frequency (spec-
ified in Hz; corresponds to number of images taken per second). Then, pupil and corneal re-
flection are segmented mostly by applying either feature-based or model-based algorithms. 
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Finally, geometric computations together with the calibration procedure are used to map the 
position of the eye to the stimulus. Therefore, the distance between the centers of pupil and 
corneal reflection is calculated, and, together with the exemplary position data gained through 
calibration, the gaze position can be estimated. 
The raw recording of eye movements typically results in eye position coordinates (x, y; ex-
pressed in pixels) with associated time stamps and is commonly transferred to degrees of visual 
angle. Thus, events (fixations, saccades, blinks) have to be detected in the raw data samples 
applying appropriate position (°), velocity (°/sec), and acceleration (°/sec²) criteria (Holmqvist 
et al., 2011). Finally, dependent variables are computed from the stream of data samples based 
on the classification of the oculomotor events and details of the task that was accomplished. 
As there are hardly any freely available computer programs to analyze SPEM data, a major part 
within the framework of the current thesis was to develop analytic routines to compute SPEM 
measures in a fast and efficient way. 
Widely used algorithms for dependent measures of SPEM, prosaccade, and antisaccade tasks 
are summarized in Table V—1 and Table V—2. 
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Table V—1. Overview of SPEM and saccade variables 
Variable Definition Computation Details 
SPEM 
Root mean square error [RMSE] 
[°] 
Deviation between eye and target position including segments of pursuit and sac-
cades 
RMSE scores are computed using the sum of the squared 
differences between eye and target position for each point 
in the SPEM segment. Finally, the square root of this sum 
divided by the number measurement points is the RMSE. 
Velocity gain [%] Ratio between eye and target velocity including only segments of pursuit (mostly 
time-weighted)  
[eye velocity / target velocity] × 100 
Saccade frequency [N/sec] Number of saccadic intrusions interrupting pursuit (there are different types of 
saccades that can either be combined or calculated separately) 
For further details see Table V—2. 
 
Pursuit latency [sec] Time that elapses between onset of stimulus movement and onset of eye acceler-
ation (used to examine the initiation of SPEM) 
The beginning of eye acceleration is specified when eye ve-
locity exceeds baseline velocity by a certain factor. Then 
eye velocity is modelled by linear regression whereas the 
slop represents the initial eye acceleration and the inter-
cept with the abscissa (time) is the latency. 
Initial eye acceleration [°/sec²] Degree of eye acceleration in response to the start of the stimulus movement 
(used to examine the initiation of SPEM) 
See above 
Prosaccades and Antisaccades 
Direction errors [%] Initial saccade after peripheral stimulus onset is executed away from (prosaccade 
error)/towards (antisaccade error) the stimulus 
% errors = number of errors / [number of correct responses 
+ number of errors] × 100 
Latency [ms] Time that elapses between onset of the peripheral stimulus and start of the sac-
cade in correct trials 
 
Amplitude gain [%] Accuracy of the initial saccade compared to the target amplitude in correct trials 
(note that given two saccades that show inaccurate gain values, these inaccuracies 
can average out resulting in a mean of 100% (e.g., (80%+120%)/2=100%)) 
% gain = amplitudesaccade / amplitudetarget × 100 
Spatial error [%] Inaccuracy of the initial saccade compared to the target amplitude in correct trials |[amplitudesaccade - amplitudetarget] / amplitudetarget × 100| 
Peak velocity [°/sec] Peak eye velocity during a saccade in correct trials  
Notes. For further information on computation algorithms refer to Ettinger et al., 2003; Lencer & Trillenberg, 2008; Smyrnis, 2008.  
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CUS compensatory in target di-
rection 
reduces eye position error; starts and ends 
behind target; if starts behind and ends 
ahead of the target, post-saccadic position 
error must be ≤50% of pre-saccadic posi-
tion error 
  Ettinger et al., 2003; Ross et al., 1998, 
2002, 2000; Ross, Olincy, Harris, et al., 
1999 
BUS compensatory opposite of 
target direc-
tion 
reduces eye position error; starts and ends 
ahead of the target; if starts ahead and 
ends behind the target, post-saccadic posi-
tion error must be ≤50% of pre-saccadic 
position error 
  Lencer et al., 1999; Levy et al., 2000; 
Radant & Hommer, 1992 
Anticipatory 
Saccade 
intrusive in target di-
rection, takes 
the eye ahead 
of the target 
starts and ends ahead of target location; if 
starts behind and ends ahead of the tar-
get, the distance ahead of the target must 
be at least twice the distance the eye 
started behind the target 
>4° followed by 
50ms of eye ve-
locity ≤50% of 
target velocity 
Ettinger et al., 2003; Olincy, Johnson, & 
Ross, 2003; Ross et al., 1998, 2002; 
Ross, Olincy, Zerbe, & Radant, 2001; 





see anticipatory saccades 1°-4° see anticipatory 
saccades 
Olincy et al., 2003; Ross et al., 2002, 
2001 
SWJ intrusive  two saccades in opposite directions, the 
first saccade increases and the second sac-
cade reduces eye position error; duration 
between the two saccades can range from 
50 to 500ms 
1°-5° eye velocity be-
tween saccades 
must be >65% 
of target veloc-
ity 
Abel & Ziegler, 1988; Clementz et al., 
1990; Friedman, Jesberger, Abel, & 
Meltzer, 1992; Lencer et al., 1999; Levy 
et al., 2000; Radant & Hommer, 1992; 
Shallo-Hoffmann, Perersen, & 
Muhlendyck, 1989 
Notes. SPEM=smooth pursuit eye movements. CUS=catch-up saccade. BUS=back-up saccade. SWJ=square wave jerks. See Smyrnis (2008) for an overview.
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V.II Latent-state-trait modeling  
LST theory is based on an extension of classical test theory and was proposed by Steyer and 
colleagues (Steyer, Ferring, & Schmitt, 1992; Steyer, Mayer, Geiser, & Cole, 2015; Steyer, 
Schmitt, & Eid, 1999; Steyer & Schmitt, 1990). Compared to classical test theory, which does 
not take into account any influences of situational aspects, LST theory assumes that not only 
the person itself but also the situation and the interaction between the person and the situa-
tion are valuable sources of variance during a measurement. Thus, “measurement does not 
take place in a situational vacuum” (Steyer et al., 1999; page 392) and variations between 
measurements are presumed to represent state differences that include person, situation, and 
person-situation interactions. LST assumes that a cross-sectional measure assesses a “person-
in-the-situation” score (Steyer et al., 2015). Furthermore, tools are provided that allow to dis-
entangle the different sources of variance (person/trait; situation, interaction between person 
and situation/state) using longitudinal study designs. 
There are several different classes of models that can be applied (e.g., multistate models, mul-
tistate-singletrait models, multistate-multitrait models) depending on the particular research 
question (Steyer et al., 2015). In order to estimate the proportion of state and trait variance in 
a multistate-singletrait model (several measurement occasions assuming a single underlying 
trait) a two-step decomposition is used: In the first step, the observed variables at each meas-
urement occasion (k) are subdivided in two test sets (i) and dismantled into latent states (Sk) 
and measurement errors (εk,i). In the second step, the latent states are decomposed into a 
latent trait variable (T) and occasion-specific state residuals (SRk) (Steyer et al., 1999). An ex-
ample is depicted in Figure VI—1a (for further fundamental assumptions that pertain to the 
methodological framework of LST refer to Steyer et al., 2015, 1999). States and traits are spec-
ified in terms of probability theory as latent random variables that can be estimated but not 
directly measured from the observed variables (Steyer et al., 2015). Structural equation mod-
eling (SEM) can be used to test the model and compute the relevant parameters. 
The components of an LST model can be conceptually identified as follows (Schermelleh-Engel, 
Keith, Moosbrugger, & Hodapp, 2004; Steyer et al., 1999): Latent state variables estimate the 
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attributes of the person and the situation during a single measurement occasion. The latent 
trait variable includes the amount of variation that is common across all measurement occa-
sions and therefore is supposed to constitute an attribute of the person itself. Finally, the oc-
casion-specific state residuals characterize the situational effects and the interactions between 
the person and the situation during a single measurement. 
After testing the model with SEM and evaluating the model fit (recommended indices: chi-
square statistic, comparative-fit index, root mean square error of approximation, and stand-
ardized root mean residual; Beauducel & Wittmann, 2005; Bentler, 2007; Hu & Bentler, 1999), 
parameters of the accepted models can be used to calculate the proportions of variances that 
quantify the situation specific and the stable trait influences of the examined measure (Steyer 
et al., 1992, 2015, 1999; Steyer & Schmitt, 1990). Common consistency 
[Con(Xk,i)=Var(T)/Var(Xk,i)] displays how well the observed variable (Xk,i) estimates the trait var-
iable (T). Occasion specificity [Spe(Xk,i)=Var(SRk)/ Var(Xk,i)] indicates how much variance of the 
observed variable (Xk,i) can be explained by the state residuals (SRk). Both common consistency 
and occasion specificity can be summed up to the coefficient of reliability 
[Rel(Xk,i)=Con(Xk,i)+Spe(Xk,i)]. Therefore, reliability [Rel(Xk,i)=Var(Sk)/Var(Xk,i)] represents the 
amount of variance of the observed variable (Xk,i) due to the latent state (Sk). 
V.III Functional magnetic resonance imaging 
fMRI allows to measure brain activation non-invasively and with relatively high spatial resolu-
tion (Logothetis, 2008). Therefore, this method has widely been used to study neural mecha-
nisms of cognitive processes (Niendam et al., 2012) and can additionally be combined with 
recording of eye movements to investigate the neural underpinnings of the oculomotor system 
(Jamadar et al., 2013). 
The fMRI method was introduced in the early 1990s (Bandettini, 2012) and is based on mag-
netization differences in different types of tissue (Huettel, Song, & McCarthy, 2008; Logothetis, 
2002). Whenever a strong magnetic field is applied to the protons of hydrogen atoms, they 
either align parallel (low-energy level) or antiparallel (high-energy level) to the field. The net 
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magnetization (difference between number of atoms in the parallel and the antiparallel state) 
provides the basis for the signal generation. Pulses of radiofrequency energy lead some nuclei 
to change from low- to high-energy states (excitation). Once these pulses are turned off, the 
equilibrium between nuclei in low- and high-energy levels is restored. The subsequent energy 
is measured (reception) and constitutes the MR signal. The MR signal changes over time (re-
laxation), resulting in the recovery of the longitudinal (T1) and the decay of the transverse (T2, 
T2*) components of net magnetization. Importantly, different types of tissues can be distin-
guished by their properties regarding the relaxation process. In order to create an image, su-
perimposed gradient magnetic fields that code spatial information are needed and Fourier 
transform is used to decode the signal. 
The most frequently used form is blood-oxygenation-level dependent (BOLD) fMRI. BOLD fMRI 
estimates brain activation indirectly from changes in blood oxygenation using T2* weighted 
scans (Ogawa, 2012; Ogawa, Lee, Kay, & Tank, 1990). The underlying assumption is that neural 
activity produces regional metabolic consequences that are linked to increases in blood flow 
in the same region, probably due to the demand for oxygen and glucose (Huettel et al., 2008; 
Logothetis & Wandell, 2004). Oxygen is delivered through hemoglobin and, importantly, deox-
ygenated hemoglobin was found to exhibit greater magnetic properties than oxygenated he-
moglobin (Pauling & Coryell, 1936). Thus, whenever the brain becomes active, more oxygen-
ated blood than needed is provided and the following decrease in the proportion of deoxygen-
ated hemoglobin results in a higher MR signal (hemodynamic response). Brain activation can 
therefore not be measured directly (Heeger & Ress, 2002). However, previous findings docu-
ment a close relationship between the BOLD signal and intra-cortical recordings of neural ac-
tivity (Goense & Logothetis, 2008; Logothetis, 2007; Logothetis, Pauls, Augath, Trinath, & 
Oeltermann, 2001) emphasizing that fMRI is a powerful tool to investigate neural processes 
spatially accurately and non-invasively. 
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VI STUDIES 
Table VI—1. Overview of studies included in the current thesis. 
 
Relevant publications for the present thesis 
1 Meyhöfer, I., Bertsch, K., Esser, M., & Ettinger, U. (2015). Variance in saccadic eye move-
ments reflects stable traits. Psychophysiology, 53, 566–578. 
http://doi.org/10.1111/psyp.12592 
2 Meyhöfer, I., Steffens, M., Kasparbauer, A., Grant, P., Weber, B., & Ettinger, U. (2015). 
Neural mechanisms of smooth pursuit eye movements in schizotypy. Human Brain Map-
ping, 36, 340–353. http://doi.org/10.1002/hbm.22632 
3 Meyhöfer, I., Kumari, V., Hill, A., Petrovsky, N., & Ettinger, U. (2016). Sleep deprivation as 
an experimental model system for psychosis: Effects on smooth pursuit, prosaccades, 
and antisaccades. Journal of Psychopharmacology, 31(4), 418-433. 
http://doi.org/10.1177/0269881116675511 
4 Meyhöfer, I., Steffens, M., Faiola, E., Kasparbauer, A.-M., Kumari, V., & Ettinger, U. (2017). 
Combining two model systems of psychosis: The effects of schizotypy and sleep depriva-
tion on oculomotor control and psychotomimetic states. Psychophysiology, 1-15. 
http://doi.org/10.1111/psyp.12917 
 
Further relevant publications 
 Ettinger, U., Meyhöfer, I., Steffens, M., Wagner, M., & Koutsouleris, N. (2014). Genetics, 
cognition and neurobiology of schizotypal personality: A review of the overlap with schiz-
ophrenia. Frontiers in Psychiatry, 5(18), 1–16. http://doi.org/10.3389/fpsyt.2014.00018 
 Steffens, M., Becker, B., Neumann, C., Kasparbauer, A. M., Meyhöfer, I., Weber, B., 
Mehta, M.A., Hurlemann, R, & Ettinger, U. (2016). Effects of ketamine on brain function 
during smooth pursuit eye movements. Human Brain Mapping, 37(11), 4047–4060. 
http://doi.org/10.1002/hbm.23294 
 Petrovsky, N., Ettinger, U., Hill, A., Frenzel, L., Meyhöfer, I., Wagner, M., Backhaus, J., & 
Kumari, V. (2014). Sleep deprivation disrupts prepulse inhibition and induces psychosis-
like symptoms in healthy humans. The Journal of Neuroscience, 34(27), 9134–9140. 
http://doi.org/10.1523/JNEUROSCI.0904-14.2014 
 Meyhöfer, I., Ettinger, U., Faiola, E., Petrovsky, N., & Kumari, V. (to be submitted). The ef-
fects of schizotypy and sleep deprivation on prepulse inhibition. 
Notes. The studies are sorted according to their relevance in the main text.  
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VI.I Study 1. Reliability of oculomotor tasks 
Meyhöfer, I., Bertsch, K., Esser, M., & Ettinger, U. (2015). Variance in saccadic eye movements 
reflects stable traits. Psychophysiology, 53, 566–578. http://doi.org/10.1111/psyp.12592 
 
Saccadic tasks have widely been studies in psychiatric disorders and are particularly useful as 
biomarkers of psychosis (Gooding & Basso, 2008). Furthermore, saccades have been studied 
in genetic research (Calkins, Iacono, & Ones, 2008; Mazhari et al., 2011), suggesting antisac-
cades to demonstrate a valuable endophenotype of psychotic disorders (Reilly et al., 2014). A 
requirement of endophenotypes is temporal stability (Glahn et al., 2014). However, there are 
only few studies that have examined the trait-like nature, i.e., the temporal stability, of sac-
cadic measures (Ettinger et al., 2003). 
The aim of the current study was to provide a detailed examination of the reliability of the 
most widely applied saccadic tasks in psychosis research. A special aim was to separate the 
amount of variance that is trans-situationally stable (trait) from variance that is situations-spe-
cific (state). As most oculomotor measures have previously been found to display moderate to 
high test-retest reliability (Ettinger et al., 2003), we hypothesized that high proportions of var-
iance can be explained by a stable trait component. 
A sample of N=68 healthy participants performed prosaccades, antisaccades, and memory-
guided saccades on three measurement occasions with an interval of one week between the 
sessions and each testing session was conducted at the same time of day. In order to investi-
gate the influences of state and trait in the saccade measures, formulas based on LST theory 
(Steyer et al., 2015, 1999) were applied. In addition to multistate-singletrait (LST) models, we 
also performed models that only assume a single underlying trait with no situations-specific 
contributions at all (singletrait models; LT models). An illustration of the models can be found 
in Figure VI—1. 
All saccadic variables could be modelled by assuming that each measurement occasion in-
cludes situations-specific variance and additionally the three occasions can be characterized 
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by a single underlying trait (LST models that include parallel or at least τ-equivalent measure-
ments for each of the three measurement occasions; Figure VI—1a). Furthermore, for some 
of the measures simpler LT models (Figure VI—1b) could be accepted. Mean saccadic variables 
of all tasks were found to represent high to excellent reliabilities. Intraindividual standard de-
viations were slightly less reliable. Most importantly, the largest part of the variance of the 
measure could be explained by the trans-situationally stable trait component and the role of 
situational aspects and person × situation interactions were rather negligible. 
In summary, prosaccade, antisaccade, and memory-guided saccade variables can be measured 
with high reliability. Additionally, the data collected in a single measurement occasion strongly 
reflect an underlying trait emphasizing its value in genetic research. Furthermore, oculomotor 
performance is stable (i.e. trait-like) in standard laboratory settings under constant conditions. 
This finding provides convincing evidence for the usefulness of antisaccades as a biomarker in 
repeated measurements, e.g., clinical trials to evaluate pharmacological treatments for cogni-
tive impairments in psychotic disorders. 
 
Figure VI—1. Schematic diagram of latent state-trait [a] and latent trait [b] models. 
Xk,i depict the observed [dependent] variables for each of the tasks [prosaccades, antisaccades, memory-guided saccades]. 
k=measurement occasion. i=test set. εk,i=measurement errors. Sk=latent states. SRk=latent state residuals. T=latent trait.  
[66]  STUDIES  
VI.II Study 2. Schizotypy and the neural mechanisms of SPEM 
Meyhöfer, I., Steffens, M., Kasparbauer, A., Grant, P., Weber, B., & Ettinger, U. (2015). Neural 
mechanisms of smooth pursuit eye movements in schizotypy. Human Brain Mapping, 36, 
340–353. http://doi.org/10.1002/hbm.22632 
 
Due to considerable overlap on different levels of measurement (Ettinger, Meyhöfer, Steffens, 
Wagner, & Koutsouleris, 2014), schizotypy is reported to represent a valuable model system 
of psychosis (Barrantes-Vidal et al., 2015). SPEM have intensively been investigated as a bi-
omarker of psychosis and performance deficits are widely replicated (Lencer et al., 2015; 
O’Driscoll & Callahan, 2008). Furthermore, studies on the neural correlates of SPEM impair-
ments in patients report abnormal brain activation in frontal and motion-sensitive posterior 
areas (Hong et al., 2005; Lencer et al., 2011; Nagel et al., 2012). Similarly, high schizotypes 
were found to demonstrate SPEM abnormalities (Table IV—2). However, no study has investi-
gated the neural mechanisms underlying the SPEM deficits in schizotypy. 
Therefore, the aim of the current study was to bridge the gap on the neural correlates of SPEM 
in schizotypy. We hypothesized that high schizotypes display lower SPEM performance than 
controls and, additionally, that the differences between schizotypes and controls will overlap 
with abnormalities seen in patients with psychotic disorders. 
To do so, n=12 schizotypes and n=19 controls underwent fMRI at 3T with concurrent oculo-
graphic recording while performing SPEM. An online version of the O-LIFE was applied to es-
tablish extreme groups of high and low schizotypes based on their overall schizotypy score. 
The key results of the study are shown in Figure VI—2. Behaviorally, high schizotypes demon-
strated higher frequency of saccadic intrusions in the slow (0.2Hz) but not the fast (0.4Hz) 
SPEM condition. At the same time, the high schizotypy group was found to display lower brain 
activation in different regions of the occipital lobe that was independent of target frequency. 
These regions (V3A, middle occipital gyrus, and fusiform gyrus) are associated with early sen-
sory/attentional processing and motion perception (Culham, He, Dukelow, & Verstraten, 
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2001). However, unlike previous studies of psychotic patients, no abnormal brain activation 
was found in frontal oculomotor areas. 
Together, these results replicate, as expected, altered SPEM performance in schizotypy (Table 
IV—2) that overlaps with impairments seen in psychotic patients (O’Driscoll & Callahan, 2008). 
Additionally, the posterior brain activation differences during SPEM are broadly in line with 
evidence of motion processing deficits from schizophrenia patients (Lencer et al., 2011; Nagel 
et al., 2012). However, in contrast to schizophrenia patients (Hong et al., 2005; Keedy et al., 
2006), we did not find any abnormalities in frontal motor areas, possibly indicating the opera-
tion of further genetic and/or illness-related influences in clinical patients. 
Figure VI—2. Illustration of the key findings of study 2. 
[a] Brain activation pattern during SPEM>baseline across all subjects (blue) and differences between groups (controls>schizotypes, 
red). Whole brain FWE corrected for SPEM>baseline across all subjects, FWEc corrected with cluster threshold k=306 for group 
differences (peak voxel threshold<.001, uncorrected). n=19 controls, n=12 schizotypes. [b] Interaction group × target frequency 
for frequency of saccadic intrusions during SPEM. n=14 controls; n=10 schizotypes.  
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VI.III Study 3. Sleep deprivation and oculomotor control 
Meyhöfer, I., Kumari, V., Hill, A., Petrovsky, N., & Ettinger, U. (2016). Sleep deprivation as an 
experimental model system for psychosis: Effects on smooth pursuit, prosaccades, and anti-
saccades. Journal of Psychopharmacology, 31(4), 418-433. http://doi.org/10.1177/026988 
1116675511 
 
Sleep deprivation has been found to cause deficits in cognitive functions (Lim & Dinges, 2010), 
e.g., oculomotor control (Table IV—4 and Table IV—5). Furthermore, sleep deprivation has 
been reported to induce psychotomimetic states (Kahn-Greene et al., 2007; Killgore et al., 
2008). Together, these discoveries suggest that studying sleep deprivation may be an experi-
mental model systems for psychosis (Ettinger & Kumari, 2015). 
Therefore, in the current study, we aimed investigate the effects of short-term sleep depriva-
tion on psychosis-like experiences and performance in the most widely used oculomotor bi-
omarkers of psychosis, i.e. SPEM and antisaccades. We expected that 24h of sleep deprivation 
would deteriorate SPEM and antisaccade measures and concurrently increase psychosis-like 
experiences. 
To do so, N=32 participants (n=16 males, n=16 females) were examined after both a normal 
sleep night and a night of total sleep deprivation. The order of the sessions (normal sleep first, 
sleep deprivation first) was counterbalanced and participants were randomly assigned to one 
of the orders. The testing sessions were conducted with one week in between. Oculomotor 
control and other tasks (e.g., PPI; Petrovsky et al., 2014) were measured in the mornings after 
normal sleep and sleep deprivation (08:00 am-09:30am). Psychotomimetic states were quan-
tified with the Psychotomimetic States Inventory (PSI; Mason, Morgan, Stefanovic, & Curran, 
2008) in the evenings before and the mornings after normal sleep and sleep deprivation. 
The main results can be found in Figure VI—3. As expected, sleep deprivation adversely af-
fected numerous SPEM (e.g., velocity gain) and antisaccade (e.g., % direction errors) variables. 
Furthermore, sleep deprivation also impacted on prosaccade measures. However, some of the 
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variables were found to show influences of the order of testing, broadly suggesting stronger 
effects of sleep deprivation when this was the first night. Additionally, sleep deprivation in-
duced psychosis-like states covering the key symptom domains of psychosis. Specifically, 
scores on perceptual distortion, cognitive disorganization, and anhedonia were higher in the 
morning after sleep deprivation compared to the evening before and the morning after the 
normal sleep night. There were no significant associations between oculomotor measures and 
psychotomimetic states. 
Figure VI—3. Illustration of the key findings of study 3. 
 
In summary, as hypothesized, sleep deprivation resulted in impairments of oculomotor control 
and increases of psychosis like states. The findings of impaired SPEM and antisaccade measures 
are in line with findings from psychosis patients with psychotic disorders (Lencer et al., 2015; 
Reilly et al., 2014). 
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VI.IV Study 4. Schizotypy, sleep deprivation, and oculomotor control 
Meyhöfer, I., Steffens, M., Faiola, E., Kasparbauer, A.-M., Kumari, V., & Ettinger, U. (2017). 
Combining two model systems of psychosis: The effects of schizotypy and sleep deprivation 
on oculomotor control and psychotomimetic states. Psychophysiology, 1-15. http://doi. 
org/10.1111/psyp.12917 
 
Schizotypy has been found to constitute a valuable approach in gaining further understanding 
of the underlying mechanism of psychosis and has commonly been investigated as a trait 
model system of psychotic disorders (Barrantes-Vidal et al., 2015). Overlaps between schizo-
typy and psychosis were found on different levels of measurement (Ettinger et al., 2014) and 
Study 2 reported schizophrenia-like SPEM and BOLD correlates of schizotypy. Additionally, in 
Study 3, it was found that one night of sleep deprivation induces psychotomimetic states and 
deteriorates oculomotor measures (Meyhöfer, Kumari, et al., 2017), emphasizing its role as a 
promising state model system of psychosis. 
As psychotic disorders are very complex and heterogeneous, a single model system will possi-
bly not be sufficient in modelling all aspects of psychosis. Therefore, the purpose of the present 
study was (1) to replicate the SPEM impairments in schizotypy from Study 2, (2) to replicate 
the effects of sleep deprivation from Study 3, and (3) to combine a trait and a state model of 
psychosis in one study to closer examine potential interactions between the model systems. 
In order to investigate the role of schizotypy, an online version of the O-LIFE (Grant et al., 2013; 
Mason et al., 2005) was used to establish extreme groups based on the positive schizotypy 
dimension. Furthermore, to study the impact of sleep deprivation, the two groups (n=17 high 
schizotypes, n=19 controls) were measured after both a normal sleep night and a night of sleep 
deprivation. The study procedure is largely the same following the previous sleep deprivation 
study (Meyhöfer, Kumari, et al., 2017; Petrovsky et al., 2014). In addition to measures of psy-
chotomimetic states (Mason et al., 2008), we also applied state measures of anxiety (Laux, 
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Glanzmann, Schaffner, & Spielberger, 1981), depression (Chiappelli, Nugent, Thangavelu, 
Searcy, & Hong, 2014), and stress (Fliege et al., 2005). 
An overview of the key results can be found in Figure VI—4. High schizotypes were found to 
demonstrate worse SPEM performance (e.g., RMSE) and higher scores on psychotomimetic 
states, anxiety, depression, and stress than the control subjects, irrespective of sleep condi-
tion. However, there were no differences between the two groups with regard to antisaccade 
performance. Sleep deprivation resulted in impairments in numerous SPEM (e.g., RMSE), anti-
saccade (e.g., % direction errors), and prosaccade variables, irrespective of schizotypy group. 
Additionally, sleep deprivation led to increased levels of perceptual distortion, cognitive disor-
ganization, anhedonia, anxiety, and depression. Most importantly, both model systems inter-
acted on SPEM velocity gain. High schizotypes but not controls displayed deteriorated gain 
after sleep deprivation compared to normal sleep. 
In summary, as expected, we replicated the SPEM impairments in schizotypy. Furthermore, we 
replicated the effects of sleep deprivation on oculomotor control and psychosis-like experi-
ences, further strengthening sleep deprivation as a reliable and valid model system of psycho-
sis (Ettinger & Kumari, 2015). Additionally, the evidence of the interaction between sleep dep-
rivation and schizotypy demonstrates that the closest approximation to psychosis can be dis-
covered in high schizotypy after sleep deprivation. This finding underlines that the combination 
of the two model systems are particularly valuable in modelling psychosis and assisting the 
development of new treatments. 
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Figure VI—4. Illustration of the key findings of study 4. 
 
VII DISCUSSION 
The current thesis is a summary of four studies that (1) examined the time stability and trait-
like nature of widely used oculomotor biomarkers of psychosis (Study 1) and (2) applied these 
biomarkers to evaluate schizotypy and sleep deprivation as two non-pharmacological human 
model systems of psychosis (Studies 2 and 4). 
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VII.I Integration 
Cognitive dysfunctions are common in psychotic disorders and are closely related to several 
psychosocial functioning variables (Chapter IV.II.II). Unfortunately, there are no effective treat-
ment options until now (Köster et al., 2014; Nielsen et al., 2015). Oculomotor tasks provide a 
solid foundation to study cognitive and neural dysfunctions in patient samples (Bey et al., 2017; 
Lencer et al., 2015; Reilly et al., 2014) and the cognitive effects of pharmacological interven-
tions (Kasparbauer et al., 2016; Reilly et al., 2008). 
Test-retest reliability and the utility as a repeated measure are key elements in the selection 
of tasks that can be applied in clinical trials, e.g., to study the effects of new antipsychotic drugs 
on cognitive functions (Nuechterlein et al., 2008). Until now, there were only few studies that 
have examined parameters of reliability for oculomotor performance, mainly reporting good 
stability over time for most of the variables (Ettinger et al., 2003; Wöstmann et al., 2013). How-
ever, no study has clearly investigated how much variance of a saccade variable either refers 
to a time stable trait or to situations-specific state influences. Therefore, we conducted a study 
of commonly used saccadic tasks and applied LST analyses (Meyhöfer, Bertsch, Esser, & 
Ettinger, 2016). We were able to demonstrate that mean saccadic measures exhibit high to 
excellent reliabilities and, additionally, the largest part of the variance could be explained due 
to trans-situationally stable consistency. In summary, one measurement occasion is sufficient 
to quantify saccade performance thereby strongly reflecting the underlying trait. Thus, oculo-
motor measures are highly valuable in study designs involving e.g., single measurement group 
comparisons. Furthermore, oculomotor performance is stable (i.e. trait-like) in standard labor-
atory settings under constant conditions. This finding underlines that saccadic tasks are useful 
in repeated measurements because the performance is stable over time under regular condi-
tions and alterations are most likely associated to e.g., pharmacological or experimental inter-
ventions. 
Together with research on practicability (Klein & Ettinger, 2008), cognitive foundations 
(Hutton, 2008), neural mechanisms (Herweg et al., 2014; McDowell et al., 2008; Talanow et 
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al., 2016), and disturbances in psychosis disorders (Chapter IV.II.III‒ii), our findings further sup-
port that antisaccades are highly valuable to evaluate the validity of cognitive alterations in 
psychosis model systems. 
Animal model systems are commonly applied in the development of novel antipsychotic com-
pounds (Pratt et al., 2012). However, modeling cognitive impairments in rats/mice and cross-
species translatability is challenging (Burrows & Hannan, 2016). Therefore, human model sys-
tems might significantly advance this field. The most studied human model systems include 
pharmacological interventions (e.g., ketamine; Steffens et al., 2016) and personality traits (e.g., 
schizotypy; Chapter IV.I.III). Schizotypy is a time-stable (Venables & Raine, 2015), multidimen-
sional attribute that includes positive, negative, and disorganized dimensions (Mason et al., 
1995; Raine et al., 1994). There are many findings of considerable overlap between schizotypy 
and patients with schizophrenia on different levels of measurement (Ettinger et al., 2014), e.g., 
both groups share impairments in the performance of SPEM (Chapters IV.II.III—ii and IV.III.I). 
To further investigate the potential overlaps in brain activation that behaviorally result in SPEM 
deficits, a high schizotypy and a control group attended an fMRI session with concurrent ocu-
lographic recording (Meyhöfer et al., 2015). The high schizotypy group was found to display 
worse SPEM together with reduced activity in occipital regions. These neural abnormalities are 
broadly in line with findings of deficits in motion processing from schizophrenia patients 
(Lencer et al., 2011; Nagel et al., 2012) and ,therefore, further stress the value of schizotypy as 
a model system of psychosis. However, in contrast to patients with schizophrenia (Chapter 
IV.II.III—ii), we did not observe any differences in frontal brain areas. 
A further promising model system of psychosis, representing a main focus of the current thesis, 
is sleep deprivation (Chapter IV.I.IV). Sleep deprivation can be applied cross-species and has 
previously been found to disrupt PPI in rats. Interestingly, the PPI disturbance could be re-
versed through the administration of antipsychotic but not anxiolytic or antidepressant drugs 
(Frau et al., 2008). Based on these results, a following study of our group replicated PPI reduc-
tions after 24 hours of sleep deprivation in healthy humans (Petrovsky et al., 2014). 
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To further validate the sleep deprivation model, we examined oculomotor functions in healthy 
participants after both a night of sleep deprivation and a night of normal sleep (Meyhöfer, 
Kumari, et al., 2017). Sleep deprivation was found to disrupt SPEM and antisaccade perfor-
mance, in line with previous studies on oculomotor function after sleep deprivation (Table IV—
4 and Table IV—5) and deteriorations reported in patients with psychosis disorders (Chapter 
IV.II.III—ii). Additionally, sleep deprivation increased psychotomimetic states comprising the 
positive, negative, and disorganized spectrum, thus validating its striking resemblance to psy-
chosis on the perceptual level. 
In order to meet the complexity of psychotic disorders, we aimed to combine the two model 
systems and investigated potential interaction between them. To do so, a high schizotypy and 
a control group participated in a night of total sleep deprivation and a night of normal sleep 
(Meyhöfer, Steffens, et al., 2017). In line with former studies (Table IV—2; Takahashi et al., 
2010), the high schizotypy group demonstrated lower SPEM performance (Meyhöfer, Steffens, 
et al., 2017) and reduced PPI (Meyhöfer et al., to be submitted; Appendix D). Sleep deprivation 
disrupted several measures of SPEM and saccade tasks and increased psychotomimetic states 
(Meyhöfer, Kumari, et al., 2017). However, the sleep deprivation induced reduction of PPI 
failed to reach statistical significance (p=.07, Meyhöfer et al., to be submitted; Appendix D). 
Most importantly, sleep deprivation reduced SPEM gain in high schizotypes but not controls. 
Thus sleep deprived high schizotypes demonstrated the closest approximation to psychosis, 
illustrating the substantial value of combining the two model systems. However, the interac-
tions between schizotypy and sleep deprivation were limited to SPEM performance. The com-
bination of the two model systems is a demanding approach and, therefore, to increase its 
significance, it would have been desirable to observe additional interactive effects on further 
important biomarkers of psychosis (i.e. antisaccades, PPI). 
Schizotypy as a well-established trait psychosis model and sleep deprivation as a promising 
non-pharmacological intervention to induce psychosis states are different conceptual ap-
proaches, with each of them possessing individual advantages. Due to low correlations be-
tween the facets (Grant et al., 2013), positive and negative levels of schizotypy can be investi-
gated fairly independently. Thereby, the distinction of the positive and the negative dimension 
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provides a useful tool to shed light on the underlying mechanisms of psychotic disorders 
(Grant, 2015). Sleep deprivation was found to cause psychotomimetic alterations that cover 
the positive, negative, and disorganized symptom spectrum of psychosis (Studies 3 and 4). 
Therefore, sleep deprivation might become a valuable alternative choice to pharmacological 
interventions, allowing the investigation of the effects of innovative treatment options for psy-
chosis in translational study designs. 
Overall, the sleep deprivation model offers crucial benefits compared to other often applied 
model systems (for overviews see Ettinger & Kumari, 2015; Everson, 1997). First, sleep depri-
vation can be employed cross-species (Frau et al., 2008; Petrovsky et al., 2014). Secondly, sleep 
deprivation was found to induce psychosis-like experiences mirroring the whole spectrum of 
symptom dimensions (Chapter IV.I.IV, Studies 3 and 4). Thirdly, cognitive deficits provoked by 
sleep deprivation overlap with impairments reported in patients with psychotic disorders 
(Chapter IV.I.IV, Studies 3 and 4). Fourthly, the effects of short-term sleep deprivation are com-
pletely reversible, supporting the safety of the model system (Azizi et al., 2017; Elmenhorst et 
al., 2017). Lastly, sleep deprivation can be administered easily and inexpensively. 
Importantly, there are also some caveats concerning the application of sleep deprivation to 
model symptoms of psychosis that need to be mentioned. Though hallucinations in psychosis 
can occur in any sensory modality, they most frequently arise in the auditory domain (American 
Psychiatric Association, 2013). In contrast, sleep deprivation rather induces visual and less 
strong auditory hallucinations (Berger & Oswald, 1962; Coren, 1998; Kollar et al., 1969). Fur-
thermore, sleep deprivation studies are not double-blind. Due to the level of drowsiness re-
lated to sleep loss and the subject’s awareness of his sleep state, both the investigator and the 
participant know the experimental condition. 
More broadly, there are also caveats that arise from restrictions of the concept of model sys-
tems in principle. Psychosis disorders are heterogeneous and complex, thus leading to a virtu-
ally impossible challenge to mimic all aspects in a single model system. Accordingly, schizotypy 
and sleep deprivation have been found to demonstrate striking overlaps on cognitive and per-
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ceptual levels but they certainly do not exhibit/produce the full picture of psychosis. Further-
more, the cognitive and perceptual overlaps between schizotypy, sleep deprivation, and psy-
chosis do not prove that they share the same etiological foundation. In principle it would also 
be conceivable that these conditions have distinct underlying molecular and cellular mecha-
nisms resulting in a similar phenotype. 
VII.II Study limitations 
The results shown in the current thesis also have limitations that need to be addressed. The 
first concerns the size and comparisons of study samples. In Studies 2 and 4, only a small num-
ber of males could be included due to low availability of males that were interested in partici-
pating. Thus, further research is needed to investigate sex differences in relation to the effects 
of schizotypy and sleep deprivation found in these studies. However, the effects of sleep dep-
rivation were generally found to be independent from sex (Study 3). Additionally, in order to 
account for differences in schizotypy scores between males and females (Fonseca-Pedrero et 
al., 2011), we applied sex-specific inclusion criteria in Study 4, but unfortunately failed to use 
this criterion in Study 2. 
In Studies 3 and 4, the participants spent a normal sleep night and a night of sleep deprivation 
in our laboratory. Some participants had problems getting to sleep in the unfamiliar stetting. 
Therefore, additional studies would profit from implementing a familiarization night. 
We observed effects of the order of testing (either normal sleep first or sleep deprivation first) 
for psychotomimetic states and oculomotor measures, broadly indicating stronger effects of 
sleep deprivation when this was the first testing occasion (Studies 3 and 4). Thus, future studies 
might benefit from deploying a between-subjects design. 
Furthermore, in order to directly draw comparisons between schizotypy, sleep deprived par-
ticipants, and psychosis patients, prospective studies should additionally include a patient 
group. 
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VII.III Future studies 
In the current thesis we have investigated the time stability and trait-like nature of saccadic 
tasks thereby demonstrating their usefulness as endophenotypes in genetic research and as 
variables in repeated measures designs. As SPEM have been proven a valuable biomarker/en-
dophenotype of psychosis, we have applied SPEM in addition to saccadic tasks to evaluate the 
validity of the schizotypy and sleep deprivation psychosis model systems. However, until now 
there is only few research on the time stability of SPEM (Ettinger et al., 2003) and further re-
search is needed to explore the reliability of different SPEM tasks and its trait-like nature. 
Sleep deprivation was previously explored as a translational model system of psychosis 
(Ettinger & Kumari, 2015) and reduced PPI could be restored through antipsychotic drugs in 
rates (Frau et al., 2008). Building upon our findings of cognitive impairments and increases of 
psychotomimetic states after sleep deprivation (Study 3 and 4), future research might benefit 
from the investigation of antipsychotic drug effects on cognition in sleep deprived humans. 
In order to discover psychosis-like alterations after sleep deprivation, we have applied the PSI 
questionnaire (Mason et al., 2008). However, this instrument does not allow to separate audi-
tory and visual hallucinatory-like experiences. As psychotic patients mostly suffer from audi-
tory hallucinations (American Psychiatric Association, 2013), future studies should have a 
closer look on the types of hallucinatory-like experiences induced through sleep deprivation. 
VII.IV Conclusions 
Overall, schizotypy and sleep deprivation were found to demonstrate considerable overlaps 
with psychosis, both on symptom and on cognitive functioning levels. The combination of the 
two models provided the closest approximation to psychosis. It may thus be concluded that 
these non-pharmacological model systems when combined with oculomotor biomarkers 
demonstrate a valuable source to investigate the underlying mechanisms of cognitive deficits 
in psychosis and to evaluate new treatment approaches. Lastly, framing the findings in the 
words of Box (1979): Schizotypy and sleep deprivation are illuminating models whose useful-
ness is highly promising.  
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